CV

CURRICULUM VITAE

Wesley Sanford Moore, M.D.

October 2016

Description Page

Education 2

Licensure 2

Academic & Professional Standing 2–4

Professional Organizations 4–5

Honors, Prizes, Fellowships, Etc. 5-6

Teaching 6

Research Grants 6-8

Committee Appointments 9–13

Fellows and Post-Doctoral Scholars 13–16

Service to Scientific Scholars 17–18

Service to Patients 18

Community Service 18

Books 18–19

Monographs 20

Bibliography 20–43

Chapters 43–58

Abstracts 58–60

Scientific Exhibits 60–61

Medical Films 61

Editorials 61

Articles Published Concerning Work 61

Scientific Presentations (2006–Present) 61–63

Wesley Sanford Moore, M.D.

Born: August 1, 1935 — San Bernardino, CA

Married: Patricia Lorenz, October 25, 1960

Children: Edward, born September 24, 1963; Michael, born February 17, 1967

EDUCATION

University of Southern California B.S., 1955

University of California School of Medicine, San Francisco M.D., 1959

MEDICAL LICENSURE

California, license #A-19266, issued 7/1/1960 to present 1960 Course attendance for recertification: Pain Management and Quality of Care,

UCLA, Los Angeles, CA, October 21-22, 2005.

Arizona license #9971, expired 8/1/2003 1977

Board Certification, Surgery, Certificate #14274,current 1966 American Board of Surgery, Certification for Special

Qualifications in General Vascular Surgery,

Certificate #256, issued Nov. 18, 1983

Recertified 1992 and October 2003 Expires 7/1/2014

California Fluoroscopy X-ray Supervisor and Operator, Certificate #RHC 147119, 2000 Expires 6/30/2012

ACADEMIC & PROFESSIONAL STANDING

Intern

University of California San Francisco

1959–60

Assistant Resident

in General Surgery

University of California Hospitals, San Francisco

1960–63

Chief Resident

in General Surgery

University of California Hospitals, San Francisco

1963–64

Captain, Medical Corps

98th General Hospital Germany

1964–66

NIH Research Fellow Cerebrovascular Insufficiency

VA Hospital San Francisco

1966–67

Chief, Vascular Surgery Section

VA Hospital San Francisco

1966–67

Clinical Instructor in Surgery

University of California School of Medicine

San Francisco

1966–68

Assistant Professor of Surgery

University of California School of Medicine

San Francisco

1968–73

Associate Professor of Surgery

University of California School of Medicine

San Francisco

1973–77

Assistant Chief of Surgery Service

VA Hospital San Francisco

1975–77

Professor of Surgery

University of Arizona College of Medicine Tucson

1977–80

Chief, Vascular Surgery Section

Arizona Health Sciences Tucson

1977–80

Chief, Vascular Surgery Section

VA Hospital Tucson

1977–80

Professor of Surgery

University of California

David Geffen School of Medicine Los Angeles

1980–2004

Chief, Vascular Surgery Section

UCLA Center for the Health Sciences, Los Angeles

1980–96

Program Director

General Vascular Surgery Residency, UCLA Center for the Health Sciences, Los Angeles

1980–96

Staff Surgeon

Wadsworth VA Hospital Los Angeles

1980–84

Staff Surgeon

Sepulveda VA Hospital Sepulveda, CA

1984–93

Professor & Chief Emeritus/

David Geffen School of Medicine at UCLA

2004–present

Attending Vascular Surgeon

Los Angeles

PROFESSIONAL ORGANIZATIONS

American Association for Medical Intervention: 1989–1995 Committee on Vascular Graft Standards

Subcommittee Chairman on Vascular Graft Coatings 1989–1995 American Board of Surgery (ABS):

Examiner ABS/Vascular Surgery 1986–1996

American College of Surgeons, Fellow 1968–present Board of Governors — 1993–1996

Nominating Committee – 1995-1996

Committee on Professional Liability – 1993–1996 ACS, Northern California Chapter — 1968–1977 Secretary-Treasurer — 1971–1977

ACS, Arizona Chapter — 1977–1980

ACS, Southern California Chapter — 1980–present Board of Directors — 1988–1994

President — 1992–1993

American Heart Association 1967–present

Fellow, Council on Cerebrovascular Disease — 1972–present Stroke Council of the American Stroke Association/

A Division of the American Heart Association Executive Committee — 1978-present Vice Chairman – 1997-1999

Chairman – 1999-2001

Chairman, Long-Range Planning Committee – 2001-2003

American Surgical Association, Fellow 1980–present

Association for Academic Surgery 1969–present

Association of VA Surgeons 1972–present

Bay Area Vascular Society 1966–1977

Secretary — 1967–77

Cleveland Vascular Society, Honorary Member 1995 European Society for Vascular Surgery 1996–present

HC Naffziger Surgical Society 1971–present

International Cardiovascular Society, North American Chapter 1969–present

International Union of Angiology 1994–present

Longmire Surgical Society 1993–present

Los Angeles County Medical Association 1985–1994 Los Angeles Surgical Society 1980–present

Pacific Coast Surgical Association 1973–present

Rocky Mountain Vascular Society (Founding Member) 1979–present

First President — 1979–1980

San Francisco Surgical Society 1970–1977

Socièté Internationale de Chirurgie/International Society 1979–1984 of Surgery, US Chapter

Society for Vascular Surgery 1973–present

Secretary — 1980–1984

President-Elect — 1985–1986

President — 1986–1987

Society of University Surgeons 1975–present

Southern California Vascular Surgical Society 1982–present (Founding Member)

President-Elect — 1982–1983

President — 1983–1984

Surgical Biology Club, III 1979–present

Western Vascular Society, Founder 1985–present

Secretary-Treasurer — 1986–1990

President-Elect — 1990–1991

President — 1991–1992

New England Society for Vascular Surgery (honorary membership) 2003–present Canadian Society for Vascular Surgery (honorary membership) 2003–present

Gold Humanism Honor Society 2007–present

HONORS, PRIZES, FELLOWSHIPS, ETC.

Phi Beta Kappa 1955

NIH Research Fellowship 1966

Who’s Who in the West 1975

Marquis Who’s Who in America 1981–present

UCLA Golden Scalpel Award for Excellence in Teaching 1984–85

Presented by the Chief Residents, Division of General Surgery 1988–89

UCLA School of Medicine

Society for Vascular Surgery, President-Elect 1985–1986 President 1986–1987

Paulo Samual Santos Medal, presented at the International 1988 Symposium in Vascular Surgery. San Lucas Hospital,

Rio de Janeiro, Brazil

American College of Surgeons, Board of Governors 1992–present Best Doctors in America 1996

America’s Top Doctor Award 2001

Castle Connolly Guide

American Heart Association 2001

Fellow of the American Heart Association and the Stroke Council

New England Society for Vascular Surgery (honorary membership) 2003–present Canadian Society for Vascular Surgery (honorary membership) 2003–present

Society for Vascular Surgery (Distinguished Fellow) 2003–present The Arnold P. Gold Foundation, Leonard Tow Humanism in Medicine Award 2007

Lifetime Achievement Award

Society of Vascular Surgery at the annual meeting June 16, 2011 2012 Dickson Emeriti Faculty Award at UCLA Medical Center April 23, 2012

Lifetime Achievement Award

by The Institute of Vascular Diseases (IVD) of Greece May 24, 2014

TEACHING

Other than Core Curriculum courses in Vascular Surgery, my teaching is carried on in the preceptor mode rather than in formally defined classes.

RESEARCH GRANTS

NIH Cooperative Study $105,000. 1973–1976 Edwards Laboratories 4,000. 1974–1975

NIH National Heart & Lung Institute 75,000. 1974–1977

Healing Complications in Vascular Surgery (per annum) 50,000. 1977–1980 Postoperative Management of Lower Extremity (per annum) 29,000. 1973–1980

Amputation; Rehabilitative Research

Engineering Research; VA 93,000. 1977–1978

Peripheral Vascular Grafting, VA (per annum) 34,000. 1974–1993 Renewal 173,000. 1987–1989

Renewal 120,000. 1990–1991

Syntex Laboratories 50,000. 1982–1988

Extracorporeal Laboratories 60,000. 1983–1989

NIH Cooperative Study: 1,300,000. 1987–1995 Asymptomatic Carotid Atherosclerosis Study (ACAS)

Member, Executive Committee

Chairman, Surgical Management Committee ACAS Follow-up (per annum) 23,125. 1994-1999

NIH/Robarts Research Institute: 106,162. 1992–1999 North American Symptomatic Carotid Endarterectomy Trial (NASCET)

UCLA Principal Investigator

Guidant/Endovascular Technologies, Inc.:

EVT Tube, Phase I, Non-Randomized (EVT Tube I) 550,000. 1992–2007 A Clinical Trial Of The EndoVascular Grafting System (EGS)

In The Treatment Of Abdominal Aortic Aneurysm (AAA) Extension Of Follow Up With CT Scan And Abdominal

X-Rays

Principal Investigator

EVT Tube, Phase II, Randomized (EVT Tube II) 350,000. 1994–2005 A Randomized Clinical Trial Of The EndoVascular Grafting

System (EGS) In The Treatment Of Abdominal Aortic Aneurysm (AAA)

Principal Investigator

EVT BiFurcated, Phase I, Non-Randomized (EVT BIF I) 180,000. 1994–2006 A Phase I Clinical Study Of The BiFurcated (Split Style) EGS

(EndoVascular Grafting System) For The Treatment Of AAA (Abdominal Aortic Aneurysm)

Co-Principal Investigator

EndoVascular Aneurysm Clinical Trial – Tube (EnACT-T) 550,000. 1996–2003 A Phase II Clinical Study Of The EGS (EndoVascular Grafting

System) As Compared To The Standard Surgical Procedure In The Treatnment Of Abdominal Aortic Aneurysm

Principal Investigator

EVT New BiFurcated, Phase I, Non-Randomized (EVT new BIF I) 215,000. 1996–2003 A Phase I Clinical Study Of The BiFurcated (Split Style) EGS

(EndoVascular Grafting System) For The Treatment Of AAA (Abdominal Aortic Aneurysm)

Co-Principal Investigator

EndoVascular Aneurysm Clinical Trial – Bifurcated (EnACT-B) 415,000. 1996–2003 A Phase II Clinical Study Of The BiFurcated (Split Style) EGS

(EndoVascular Grafting System) As Compared To The Standard Surgical Procedure In The Treatment Of AAA (Abdominal Aortic Aneurysm)

Co-Principal Investigator

EndoVascular Aneurysm Clinical Trial – Aortoiliac (EnACT-A) 225,000. 1996–2004 A Phase II Clinical Study Of The Aortoiliac (Funnel Style)

EGS (EndoVascular Grafting System) As Compared To The Standard Surgical Procedure In The Treatment Of AAA (Abdominal Aortic Aneurysm)

Principal Investigator

EndoVascular Aneurysm Clinical Trial (Ancure™) – 480,000. 1998–2005 Ancure™ Tube and Bifurcated (AncureTM)

Clinical Study of the Ancure Tube and Bifurcated Systems – Extended Indications Evaluation

Principal Investigator

NIH/McMaster University: 19,800. 1994–1999 Aspirin and Carotid Endarterectomy (ACE)

UCLA Principal Investigator

Subcontract with UMDNJ (University of Medicine and Dentistry, New Jersey) and NIH and Guidant, Inc.: 75,000. 2003–present

Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST)

Principal Investigator

SubContract with CCF (Cleveland Clinic Foundation) and Medtronic, Inc.: 31,134. 2007–present

Positive Impact of EndoVascular Options for Treating Aneurysm EarLy (PIVOTAL)

Principal Investigator

COMMITTEE APPOINTMENTS

VA Hospital, San Francisco

Human Studies Committee 1969–1972

Utilization Review Committee 1969–1977

Medical Records Committee, Chairman 1969–1972

Research & Education Committee 1970–1973

Budget & Evaluation Committee 1971–1973

Medical Isotope Committee 1971–1976

Metabolic Ward Committee 1971–1976

Physicians & Nurse Anesthetists, Alternate Secretary 1971–1973 Professional Standards Board

Tissue & Transfusions Committee

Space Management Committee 1974–1977

University of California, San Francisco

Campus Committee on Human Research 1975–1977

Ad Hoc Review Committee for Faculty Promotion 1969–1977

School of Medicine:

Dean’s Committee for Medical Program in Fresno 1975–1977

Search Committee for Associate Dean of Medical Program 1975–1977 Therapeutic Agents & Pharmacy Committee 1977

Department of Surgery:

Search Committee for Chief of Urology 1975–1977

University of Arizona Health Sciences Center

Research & Development Committee 1977–1980

Physical & Occupational Therapy Committee 1977–1980

Advisory Committee on Rehabilitation Services 1977–1980

Research Space Subcommittee 1977–1980

Department of Surgery Promotion & Tenure Committee 1978–1980

Department of Neurology Promotion & Tenure Committee 1978–1980

Radiology Review Committee 1978–1980

Medical Service Plan Committee 1979–1980

Ad Hoc Committee on Ambulatory Care, Chairman 1979 Ambulatory Care Committee 1979–1980

Rehabilitation Center Services Committee 1979–1981 Ad Hoc Space Committee 1979

University of California, Los Angeles Center for the Health Sciences

Ad Hoc Committee for Vascular Access Surgery 1980 Quality Care Committee

Department of Surgery Executive Committee

1980

General Surgery Committee on Medical Staff Appointments

1980

Ad Hoc Committee for Preferred Provider Organizations (PPOs)

1983

Advisory Committee, Postgraduate Medical Education

1983–1984

Search Committee for Chief of Staff position

1983

Sepulveda VA Hospital

Legislative Assembly Representative (academic appointment) 1984–1986

Academic Senate, Executive Committee for Dept. of Surgery 1984–1985 President

Chancellor’s Animal Research Committee 1984–1989 Department of Surgery Representative to Ad Hoc Committee 1985

for Review of Admission Practices for Surgery

Member, Bruincare Board of Directors 1985–1987

Member, Postgraduate Education Advisory Committee 1985–1987

Member, Division of General Surgery Executive Committee 1986–1991

Member, University Extension Committee 1986–1988 Ad Hoc Committee on Quality Assurance Procedure 1986 Chairman, General Surgery Planning Committee 1987–1991

for Outpatient Care Center

Member, Ad-Hoc Committee on UCLA Medical Center Stock 1987 and Stock Options

Elected Member, Department of Surgery Executive Committee 1987–1994

Patterns of Financial Support Task Force 1987–1992

Physician Incentives Task Force 1987-1992

Member, Faculty Advisory Committee on Billing 1987–1990

Committee on Cardio-Vascular Laser Center, Chairman 1988-1990

Surgicenter Policy Committee 1990–1992

Member, Strategic Plan for Clinical Programs 1991 Task Force on Finance Committee

Chairman, W. Eugene Stern Chair Search Committee 1991

Member, Department of Surgery Executive Committee 1991–1994

Member, Academic Senate Executive Committee 1991–1094

Member, Search Committee for Executive Director, 1992 UCLA Medical Group

Member, Committee on Compensation for Billing and Collection 1993–1995

Member, Ethics Committee 1993–1995

Member, General Surgery Advisory Committee 1994–1996

Appointee, Volunteer Clinical Appointments and Promotions Committee 1996–present Member, College of Applied Anatomy Advisory Council 2000–present

Regional

Regional Medical Programs Task Force for Stroke 1967–1969 International Cardiovascular Society:

Local Arrangements Committee 1971

Member, Executive Council for Investigative Study, 1991–present Thrombolysis vs. Surgery in Peripheral Vascular

Thrombotic Occlusion

State

Examiner: California State Board of Medical Examiners 1970–1977

Physician Advisor: California Medical Review, Inc. 1991–1992 Reappointed 1992–1996

National

American Board of Surgery Examination:

Examiner 1980

Associate (Guest) Examiner 1984

Examiner, Certification for Special Qualifications 1986–1996 in General Vascular Surgery

American College of Surgeons:

Cardiovascular Committee 1980–1983

Senior Member 1986–1989

Executive Committee of Cardiovascular Committee 1981, 1983–1986 Vice Chairman, 1985–86

Program Chairman, Vascular Course given at the 1984–1986 Annual Meeting, October 19–24, 1986, New Orleans, LA

Nominating Committee 1995–1996

Board of Governors 1993–1996

American Heart Association:

Stroke Council of the American Stroke Association/

A Division of the American Heart Association

Executive Committee 1978–2002

Nominating Committee 1979–1980

Program Committee on International Joint Stroke 1981, 1982 Conference

Assembly Alternate Delegate, International Joint 1981 Stroke Conference

Committee on Student Clerkships 1981, 1982 Chairman, The International Affairs Committee 1996–2002

Vice Chairman, Stroke Council 1997-1999 Chairman, Budget Committee 1997-1999

Member, Science Advisory and Coordinating Committee 1998–2001 Chairman, Stroke Council 1999-2001

Chairman, Long-Range Planning Committee 2001-2003 Program Committee, Council on Cardiovascular Surgery 1983

Chairman, Vascular Surgery Program at the Annual Meeting, 1984 Miami Beach, FL

Student Scholarships Committee, Council on Stroke 1983–2000

Science Advisory and Coordinating Committee 1998-1999

National Institutes of Health:

Member, Surgery & Bio-engineering Study Section of 1985–1987 the Division of Research Grants

Society for Vascular Surgery:

Program Committee 1979

Membership Committee 1979–1988

Advisory Committee on Certification and Accreditation 1986–1988

President, Lifeline Foundation 1991–1992

Board of Technology and Clinical Studies 2001–present

Joint Council, Society for Vascular Surgery/International Society for Cardiovascular Surgery

Chairman, Vascular Surgical Privilege Committee

1987–1989

Chairman, Ad Hoc Committee Concerning Practice

Guidelines for Carotid Endarterectomy

1990–1992

Chairman, Ad Hoc Committee on Postgraduate Training

1995-1997

and Education

Accreditation Council for Graduate Medical Education:

Member, Board of Appeals 1985–1988

American Association for Medical Intervention 1989–1996 Committee on Vascular Graft Standards

Subcommittee Chairman on Vascular Graft Coatings

International

International Cardiovascular Society:

Membership Committee, North American Chapter 1977–2002 (United States & Canada)

Member, Executive Council for Investigative Study, 1991–2002 Thrombolysis vs. Surgery in Peripheral Vascular

Thrombotic Occlusion

FELLOWS AND POST-DOCTORAL SCHOLARS

Fellows in Vascular Surgery

Carol A. Raviola, MD 1980–1981

Attending Surgeon, Pennsylvania Hospital Assistant Clinical Professor of Surgery, University of Pennsylvania

Sherwood Dixon, MD 1981–1982

Private Practice, Reno, Nevada

William J. Quiñones-Baldrich, MD 1982–1983

Professor of Surgery

David Geffen School of Medicine at UCLA

James L. Skydell, MD 1983–1984

Private Practice, Santa Monica, California

Sam S. Ahn, MD 1984–1985

CEO and Founder, Vascular Management Associates Los Angeles, California

C. William Cole, MD, FRCSC 1985–1986

Kaiser-Permanente

Los Angeles, California

Julie A. Freischlag, MD 1986–1987

William Stewart Halsted Professor and Chair, Department of Surgery

The Johns Hopkins Medical Institutions

James M. Kunkel, MD 1987–1988

Deceased 1990

Hugh A. Gelabert, MD 1988–1989

Professor of Surgery

David Geffen School of Medicine at UCLA

Paul A. Gores, MD 1989–1990

Director of Pancreas and Islet Transplantation Carolinas Medical Center Transplant Center Charlotte, North Carolina

Raymond Makhoul, MD 1990–1991

Private Practice Richmond, Virginia

Arun Chervu, MD 1991–1992

Private Practice Murietta, Georgia

David H. Deaton, MD 1992–1993 Professor of Surgery

Chief of Endovascular Surgery

Georgetown University Division of Vascular Surgery

Richard W. Bock, MD 1993–1995 Private Practice

Asheville, North Carolina

Rhoda Leichter, MD 1994–1995 Private Practice

Los Angeles, California

Michael D. Colburn, MD 1995-1996 Private Practice,

Traverse City, Michigan

Gabriel G. Carabello, MD

1996-1997

Private Practice

Los Angeles, CA

Vikram S. Kashyap, MD

1997-1998

The Cleveland Clinic Foundation Cleveland, OH

Pavel Petrik, MD 1998-1999 Private Practice

Lancaster, CA

Fernando Kafie, MD 1999-2000 Private Practice

Pensacola, Florida

Niren Angle, MD 1999-2001 Associate Professor of Surgery University of California San Diego

David A. Rigberg, MD 2000-2002 Assistant Professor of Surgery

David Geffen School of Medicine at UCLA

John Lane, MD 2001-2003 Associate Clinical Professor University of California Irvine

Todd D. Reil, MD 2002-2004

Associate Professor of Surgery Director of Endovascular Surgery University of Minnesota

Bryce Beseth, MD 2003-2005 Private Practice

Upland, California

Sydney Guo, MD 2004-2006 Private Practice

Falls Church, VA

Juan Carlos Jimenez, MD 2005-2007 Assistant Professor of Surgery

David Geffen School of Medicine at UCLA

Kristen Biggs, MD 2006-2008 University of New Mexico

Jessica O’Connell, MD 2007-present Ankur Chandra, MD 2008-present

Post-Doctoral Scholars

Anthony Salvian, MD 1983

Assistant Professor of Surgery University of British Columbia

Vicente Martin-Paredero, MD 1983

Faculty Member, School of Medicine University of Madrid, Spain

Sherif El-Massry, MD 1986–1988

Extramural candidate for PhD degree El Mansoura University, Egypt

Abdal Hamid Omar Askar, MD 1988–1989

A.L. of Surgery

Cairo University, Egypt

Hany Nowara, MD 1989–1990

Extramural Candidate for PhD degree Cairo University, Egypt

Young-Min Woo, MD 1998-1999 Seoul, Korea

Kei Kwong Wong, MD 1999

Medical Officer, Tuen Mun Hospital, Hong Kong

Guo-yu Chen, MD 2000

Chairman of Surgery, First Affiliated Hospital of Nanjing Medical University Nanjing, PR China

Ali Fuat Paker, MD 2001 Bursa, Turkey

Mamdouh M. Almezaien, MD 2001 Suez Canal University, Ismailia, Egypt

SERVICE TO SCIENTIFIC SCHOLARS

Editorial Board, The Geriatric Amputee (Monograph), 1968 National Research Council Committee on Prosthetic Research and Development

Editorial Board, Handbook on Lower Extremity Amputations 1969 (Monograph), National Research Council Committee on Prosthetic-Orthotic Education

Reviewer, Journal of Surgical Research 1974–1986

Editorial Advisory Board, Biology of Surgical Infection 1978–1996 (Monograph Series), Chirurgecom, Plainfield, NJ

Editorial Advisory Board, Bulletin of Prosthetics Research 1978 Rehabilitative Engineering R&D Service

Veterans Administration

Editorial Advisory Board, Vascular Diagnosis & Therapy 1980–1996 Journal published by Brentwood Publishing Corporation

Editorial Board, Journal of Surgical Research 1980–1986

Editorial Advisory Board, Journal of Clinical Surgery, 1981–1982

Applied Physiology and Metabolism

Editorial Board Member, Stroke 1981–1986

American Heart Association

Editorial Board, Journal of Vascular Surgery 1983–2001 Reappointed, 1985, 1988, 1990, 1993, 1995, 1997, 1998

Annals of Vascular Surgery (an international journal of vascular surgery published in Europe) Editorial Board 1985–2002

Member, Board of Directors 2002–present

Editorial Board, International Vascular Surgery 1991–present

Senior Editor, EndoCardioVascular Multimedia Magazine 1998–present Editorial Panel, Indian Journal of Vascular and Endovascular Surgery 1999–present Editorial Board, Vascular 2003–present

SERVICE TO PATIENTS

Established program of below-knee amputation with 1968 immediate postoperative fitting, VA Hospital

San Francisco

Established Peripheral Vascular Diagnostic Laboratory 1969 VA Hospital, San Francisco

Established detection program for the stroke-prone patient 1969 VA Hospital, San Francisco

Established Vascular Diagnostic Laboratory 1977

Arizona Health Sciences Center

Established Cardio-Vascular Laser Center, UCLA 1989

COMMUNITY SERVICE

Consultant, Medical Policy Committee of Blue Cross 1987–1996 of California

BOOKS

1. Rutherford RB, Bernhard V, Maddison FE, Moore WS, Perry M, Sumner D (Eds). Vascular Surgery. W.B. Saunders Co., Philadelphia, PA, 1977.

2. Moore WS (Ed). Vascular Surgery: A Comprehensive Review. Grune & Stratton, New York, NY, 1983.

3. Rutherford RB (Ed); Moore WS (Assoc. Ed); Kempczinski RF, Smith G, Sumner D, Johnson GJ, Perry MO, Bergan JJ, Dean LR, Kumpe DA, Roose D, Wolfe JHN (Eds). Vascular Surgery, Second Edition. W.B. Saunders Company, Philadelphia, PA, 1984.

4. Moore WS (Ed). Vascular Surgery: A Comprehensive Review, Second Edition. Grune & Stratton, New York, NY, 1986.

5. Moore WS (Ed). Surgery for Cerebrovascular Disease. Churchill Livingstone, New York, NY, 1987.

6. Moore WS, Malone JM (Eds). Lower Extremity Amputation. W.B. Saunders Company, Orlando, FL, 1989.

7. Moore WS, Ahn SS (Eds). Endovascular Surgery. W.B. Saunders Company, Philadelphia, PA, 1989.

8. Rutherford RB (Ed); Johnson G Jr, Kempczinski RF, Moore WS, Perry MO, Smith GW, Sumner DS (Assoc. Eds); Bergan JJ, Dean RH, Johnston KW, Kumpe DA, Malone JM, Riles TS, Wolfe JHN (Asst. Eds). Vascular Surgery, Third Edition. W.B. Saunders Company, Philadelphia, PA, 1989.

9. Moore WS (Ed). Vascular Surgery: A Comprehensive Review, Third Edition. Grune & Stratton, New York, NY 1991.

10. Ahn SS, Moore WS (Eds). Endovascular Surgery, Second Edition. W.B. Saunders Company, Philadelphia, PA 1992.

10a. Ahn SS, Moore WS (Eds). Chirurgia Endovascolare, II Edizione (Endovascular Surgery, Second Edition). Edizione italiana a cura di A.M. Raso – P. Rispoli. Edizioni Minerva Medica, Torino, Italy, 1997.

11. Moore WS (Ed). Vascular Surgery: A Comprehensive Review, Fourth Edition. W.B. Saunders Company, Philadelphia, PA 1993.

12. Caplan LR, Shifrin EG, Nicolaides AN, Moore WS (Eds). Cerebrovascular Ischaemia: Investigation & Management. Med-Orion Publishing Company, London, England, 1996.

13. Moore WS (Ed). Surgery for Cerebrovascular Disease, Second Edition. W.B. Saunders Company, Philadelphia, PA 1996.

14. Moore WS (Ed). Vascular Surgery: A Comprehensive Review, Fifth Edition. W.B. Saunders Company, Philadelphia, PA 1998.

15. Moore WS, Ahn SS (Eds). Endovascular Surgery, Third Edition. W.B. Saunders Company, Philadelphia, PA 2001.

`

16. Moore WS (Ed). Vascular Surgery: A Comprehensive Review, Sixth Edition. W.B. Saunders Company, Philadelphia, PA, 2001.

17. Moore WS (Ed). Vascular and Endovascular Surgery: A Comprehensive Review, Seventh Edition. Saunders Elsevier, Philadelphia, PA 2006.

18. Moore WS, Ahn SS (Ed). Endovascular Surgery, Fourth Edition. Elsevier Saunders, Philadelphia, PA 2010

19. Moore WS, Jimenez JC (Eds) A Handbook of Vascular Disease Management. Word Scientific 2011

20. Moore WS (Ed) Vascular and Endovascular Surgery. A Comprehensive Review, Eighth Edition. Saunders Elsevier, Philadelphia, PA 2012

MONOGRAPHS

1. Moore WS, Blaisdell FW. Diagnosis and Management of Peripheral Vascular Occlusive Disease. Curr Prob Surg, November 1973.

2. Moore WS. Skin Blood Flow and Healing. Bull Prosthet Res 10–22, Fall 1974.

3. Moore WS. Infrainguinal Vascular Graft Failure. Seminars in Vasc Surg 3(1), March 1990.

4. Gelabert HA, Moore WS. Carotid Endarterectomy: Current Status. Current Problems in Surgery, XXVIII: 3 March 1991.

5. Moore WS, Gelabert HA. Antibiotic-Impregnated Vascular Grafts. Medical Intelligence Unit,

R.G. Landes Co., October 1992.

6. Moore WS. Current Status of Carotid Endarterectomy. Seminars in Vasc Surg 8(1), March 1995.

BIBLIOGRAPHY

1. Moore WS, Blaisdell FW, Gardner M, Hall AD. Effect of infection on autogenous vein arterial substitutes. Surg Forum 1962; 13: 235–237.

2. Moore WS, Blaisdell FW, Hall AD. Polycythemia vera—Peripheral vascular manifestations. Calif Med 1964; 100: 92–96.

3. Moore WS, Blaisdell FW, Hall AD. Retrograde thrombectomy for chronic occlusion of the common carotid artery. Arch Surg 1967; 95: 664–673.

4. Lim RC Jr, Blaisdell FW, Hall AD, Moore WS, Thomas AN. Below knee amputation for ischemic gangrene. Surg Gynecol Obstet 1967; 125: 493–501.

5. Moore WS, Preger L, Hall AD, Maddison FE. Abdominal aortic aneurysms—Unusual clinical manifestations. Calif Med 1968; 108: 345–349.

6. Moore WS, Hall AD. Ulcerated atheroma of the carotid artery—A cause of transient cerebral ischemia. Am J Surg 1968; 116: 237–242.

7. Moore WS, Rosson CT, Thomas AN, Hall AD. The mechanism for hypertension following cerebral ischemia. Surg Forum 1968; 19: 396–398.

8. Moore WS, Cafferata HT, Hall AD, Blaisdell FW. In defense of grafts across the inguinal ligament: An evaluation of early and late results of aortofemoral bypass grafts. Ann Surg 1968; 168: 207–214.

9. Moore WS, Hall AD, Wylie EJ. Below knee amputation for vascular insufficiency—Experience with immediate postoperative fitting of prosthesis. Arch Surg 1968; 97: 886–893. Reprinted Bull Prosth Res, Fall 1969.

10. Moore WS, Rosson CT, Hall AD, Thomas AN. Transient bacteremia—A cause of infection in prosthetic vascular grafts. Am J Surg 1969; 117: 342–343.

11. Buscaglia LC, Moore WS, Hall AD. False aneurysm after carotid endarterectomy. Report of a case. JAMA 1969; 209: 1529.

12. Maddison FE, Moore WS. Ulcerated atheroma of the carotid artery: Arteriographic appearance. Am J Roentgenol 1969; 107: 530–534.

13. Moore WS, Hall AD. Carotid artery back pressure—A test of cerebral tolerance to temporary carotid occlusion. Arch Surg 1969; 99: 702–710.

14. Hall AD, Zubrin JR, Moore WS, Thomas AN. Surgical treatment of aortic aneurysm in the aged. Arch Surg 1970; 100: 455–460.

15. Goldstone J, Moore WS, Hall AD. Chronic occlusion of the superior and inferior mesenteric veins. Report of a case. Am Surg 1970; 36: 235–237.

16. Cohn LH, Moore WS, Hall AD. Extra-abdominal management of late aorto-femoral graft thrombosis. Surgery 1970; 67: 775–779.

17. Kihn RB, Golbranson FL, Hutchinson RH, Moore WS, Premer RF, et al. The immediate postoperative prosthesis in lower extremity amputations. Arch Surg 1970; 101: 40–44.

18. Moore WS, Hall AD. Pathogenesis of arterial hypertension following cerebral arterial occlusion. Surg Gynecol & Obstet 1970; 131: 885–893.

19. Blaisdell FW, Hall AD, Lim RC, Moore WS. Aorto-iliac arterial substitution utilizing subcutaneous grafts. Ann Surg 1970; 172: 775–780.

20. Moore WS, Hall AD. Late suture failure in the pathogenesis of anastomotic false aneurysms. Ann Surg 1970; 172: 1064–1068.

21. Moore WS, Hall AD. Importance of emboli from carotid bifurcation in pathogenesis of cerebral ischemic attacks. Arch Surg 1970; 101: 708–716.

22. Moore WS, Rosson CT, Hall AD. Effect of prophylactic antibiotics in preventing bacteremic infection of vascular prostheses. Surgery 1971; 69: 825–828.

23. Clark OH, Moore WS, Hall AD. Radiographically occluded, anatomically patent carotid arteries. Arch Surg 1971; 102: 604–606.

24. Moore WS, Hall AD, Blaisdell FW. Late results of axillary-femoral bypass grafting. Am J Surg 1971; 122: 148–154.

25. Moore WS, Hall AD. Unrecognized aortoiliac stenosis—A physiologic approach to the diagnosis. Arch Surg 1971; 103: 633–638.

25a. Moore WS. Reflections on the mechanism and significance of arterial hypertension following cerebral arterial occlusion. Am Heart J 1972; 83: 286–287.

26. Moore WS, Hall AD, Lim RC. Below the knee amputation for ischemic gangrene—Comparative results of conventional operation and immediate postoperative fitting technique. Am J Surg 1972; 124: 127–134.

27. Moore WS, Hall AD, Allen RE. Tensile strength of arterial prosthetic anastomoses. J Surg Res 1972; 13: 209–214.

28. Sydorak GR, Moore WS, Newcomb L, Campagna G, Hall AD. Effect of increasing flow rates and arterial caliber on critical arterial stenoses. Surg Forum 1972; 23: 243–244.

29. Moore WS, Hall AD. Effects of lumbar sympathectomy on skin capillary blood flow in arterial occlusive disease. J Surg Res 1973; 14: 151–157.

30. Moore WS, Yee JM, Hall AD. Collateral cerebral blood pressure—An index of tolerance to temporary carotid occlusion. Arch Surg 1973; 106: 520–523.

31. Swanson RJ, Moore WS, Campagna G. Effect of time on vascular prostheses’ susceptibility to infection of bacteremic origin. Surg Forum 1973; 24: 28–29.

32. Moore WS, Sydorak GR, Newcomb L, Campagna G. Blood pressure gradient to estimate flow changes with progressive arterial stenosis. Surg Forum 1973; 24: 248–250.

33. Moore WS. Determination of amputation level—Measurement of skin blood flow with xenon Xe 133. Arch Surg 1973; 107: 798–802.

34. Moore WS, Bossart KJ, Maddison F. The effectiveness of vena caval ligation in preventing emboli from small thrombi of varying consistency. J Cardiovasc Surg, 1973; Special Issue for 11th World Congress of the International Cardiovascular Society, Communications of Vascular Surgery, pp 523–528.

35. Goldstone J, Moore WS. Infection in vascular prostheses—Clinical manifestations and surgical management. Am J Surg 1974; 128: 225–233.

36. Moore WS, Swanson RJ, Campagna G, Bean B. Pseudointimal development and vascular prostheses’ susceptibility to bacteremic infection. Surg Forum 1974; 25: 250–252.

37. Moore WS, Swanson RJ, Campagna G, Bean B. The use of fresh tissue arterial substitutes in infected fields. J Surg Res 1975; 18: 229–233.

38. Malone JM, Moore WS, Campagna G, Bean B. Bacteremic infectibility of vascular grafts: The influence of pseudointimal integrity and duration of graft infection. Surgery 1975; 78: 211–216.

39. Malone JM, Moore WS, Goldstone J. The natural history of bilateral aortofemoral bypass for ischemia of the lower extremities. Arch Surg 1975; 110: 1300–1306.

40. Goldstone J, Moore WS. Emergency carotid artery surgery in neurologically unstable patients. Arch Surg 1976; 111: 1284–1291.

41. Moore WS, Bean B, Burton R, Goldstone J. Use of the Doppler flowmeter in stroke prevention. Med Progr Technol 1976; 4: 117–121.

42. Moore WS, Malone JM, Goldstone J. Extrathoracic repair of branch occlusions of the aortic arch. Am J Surg 1976; 132: 249–257.

43. Wright RA, Yang F, Moore WS. Tuberculous infection in a vascular prosthesis—A case of aortic graft infection resulting from disseminated tuberculosis. Arch Surg 1977; 112: 79–81.

44. Malone JM, Moore WS, Goldstone J. Life expectancy following aortofemoral arterial grafting. Surgery 1977; 81: 551–555.

45. Moore WS, Bean B, Burton R, Goldstone J. The use of ophthalmosonometry in the diagnosis of carotid artery stenosis. Surgery 1977; 82: 107–115.

46. Roon AJ, Moore WS, Goldstone J, et al. Comparative surface thrombogenicity of implanted vascular grafts. J Surg Res 1977; 22: 165–173.

47. Roon AJ, Malone JM, Moore WS, et al. Bacteremic infectibility: A function of vascular graft material and design. J Surg Res 1977; 22: 489–498.

48. Roon AJ, Moore WS, Goldstone J. Below-knee amputation: A modern approach. Am J Surg 1977; 134: 153–158.

49. Eisenberg RL, Nemzek WR, Moore WS, Mani RL. Relationship of transient ischemic attacks and angiographically demonstrable lesions of carotid artery. Stroke 1977; 8: 483–486.

50. Eugene J, Goldstone J, Moore WS. Fifteen year experience with subcutaneous bypass grafts for lower extremity ischemia. Ann Surg 1977; 186: 177–183.

51. Moore WS, Malone JM. The use of prophylactic antibiotics in vascular surgery. J Surg Pract 1977; 6: 24–30.

52. Boren CH, Roon AJ, Moore WS. Maintenance of viable arterial allografts by cryopreservation. Surgery 1978; 83: 382–391.

53. Goldstone J, Malone JM, Moore WS. Inflammatory aneurysms of the abdominal aorta. Surgery 1978; 83: 425–430.

54. Goldstone J, Moore WS. A new look at emergency carotid artery operations for the treatment of cerebrovascular insufficiency. Current Concepts 1978; 13: 15–18.

55. Moore WS. The importance of amputation-level determination. BPR 1977; 10–28: 1–3.

56. Goldstone J, Malone JM, Moore WS. Importance of the profunda femoris artery in primary and secondary arterial operations for lower extremity ischemia. Am J Surg 1978; 136: 215–220.

57. Malone JM, Gervin AS, Kischer CW, Keown K, Moore WS. Venous fibrinolytic activity and histologic features with distention. Surg Forum 1978; 29: 479–480.

58. Moore WS, Boren CB, Malone JM, et al. Natural history of nonstenotic asymptomatic ulcerative lesions of the carotid artery. Arch Surg 1978; 113: 1352–1359.

59. Goldstone J, Moore WS. A new look at emergency carotid artery operations for the treatment of cerebrovascular insufficiency. Stroke 1978; 9: 599–602.

60. Malone JM, Goldstone J, Moore WS. Autogenous profundaplasty: The key to long-term patency in secondary repair of aortofemoral graft occlusion. Ann Surg 1978; 188: 817–823.

61. Moore WS, Malone JM. Vascular reconstruction in the diabetic patient. Angiol 1978; 29: 741–748.

62. Moore WS, Malone JM. Effect of flow rate and vessel calibre on critical arterial stenosis. J Surg Res 1979; 26: 1–9.

63. West H, Burton R, Roon AJ, Malone JM, Goldstone J, Moore WS. Comparative risk of operation and expectant management for carotid artery disease. Stroke 1979; 109: 117–121.

64. Malone JM, Moore WS, Goldstone J, Malone SJ. Therapeutic and economic impact of a modern amputation program. Ann Surg 1979; 189: 798–802.

65. Moore WS, Boren C, Malone JM, Goldstone J. Asymptomatic carotid stenosis—Immediate and long-term results after prophylactic endarterectomy. Am J Surg 1979; 138: 228–233.

66. Blaisdell FW, Moore WS, Vetto RM, Mannick JA. Symposium: Extra-anatomic vascular shunt. Contemp Surg 1979; 15: 69–82.

67. Malone JM, Gervin AS, Moore WS, et al. Tumor interaction with the fibrinolytic system. J Surg Res 1979; 26: 581–589.

68. Malone JM, Wangensteen SL, Moore WS, Keown K: The fibrinolytic system—A key to tumor metastasis? Ann Surg 1979; 190: 342–349.

69. Malone JM, Moore WS, Goldstone J, Malone SJ. Therapeutic and economic impact of a modern amputation program (reprinted from Ann Surg 189, 1979). Bull Prosth Res, Fall 1979; pp. 7–17.

70. Malone JM, Bean B, Laguna J, Hamilton R, LaBadie E, Moore WS. Diagnosis of carotid artery stenosis—Comparison of oculoplethysmography and Doppler supraorbital examination. Ann Surg 1980; 191: 347–353.

71. Malone JM, Moore WS, Hamilton R, Smith M. Combined carotid–vertebral vascular disease. Arch Surg 1980; 115: 783–785.

72. Leal JM, Malone JM, Moore WS, Malone SJ. For accelerated post-amputation rehabilitation: Zoroc intermediate prostheses. Orthotics and Prosthetics, 1980; 34: 3–12.

73. Moore WS, Malone JM, Keown K. Prosthetic arterial graft material—Influence on neointimal healing and bacteremic infectibility. Arch Surg 1980; 115: 1379–1383.

74. Moore WS, Henry RE, Malone JM, Daly MJ, Patton D, Childers SJ. Prospective use of Xenon Xe 133 clearance for amputation level selection. Arch Surg 1981; 116: 86–88.

75. Moore WS. Introduction—Amputation symposium. Arch Surg 1981; 116: p79.

76. Moore WS. Limb salvage vs. limb ablation. Contemporary Surgery 1981; 18: 57–60.

77. Moore WS. Epitome. Western J Med 1980; 133: 505–511.

78. Malone JM, Moore WS, Leal JM, Childers SJ. Rehabilitation for lower extremity amputation. Arch Surg 1981; 116: 93–98.

79. Malone JM, Moore WS, Kischer CW, Keown K, Conine R. Venous cryopreservation: Endothelial fibrinolytic activity and histology. J Surg Res 1980; 29: 209–222.

80. Malone JM, Misiorowski RL, Moore WS, Chvapil M. Influence of prosthetic graft fabrication on graft healing. J Surg Res 1981; 30: 443–448.

81. Malone JM, Leal JM, Moore WS, Henry RE, Daly MJ, Patton DD, Childers SJ. The “gold standard” for amputation level selection: Xenon-133 clearance. J Surg Res 1981; 30: 449–455.

82. Malone JM, Kischer CW, Moore WS. Changes in venous endothelial fibrinolytic activity and histology with in vitro distension and arterial implantation. Am J Surg 1981; 142: 178–182.

83. Hunter GC, Sieffert G, Malone JM, Moore WS. The accuracy of carotid artery back pressure as an index for shunt requirements: A reappraisal. Stroke 1982; 13: 319–326.

84. Osborne RW, Malone JM, Hunter GC, Moore WS. Endothelial fibrinolytic activity: The key to postangiographic thrombosis? Surg Forum 1981; 32: 328–330.

85. Sieffert GF, Keown K, Moore WS. Pathologic effect of tobacco smoke inhalation on arterial intima. Surg Forum 1981; 32: 333–335.

86. Moore WS, Chvapil M, Sieffert G, Keown K. Development of an infection-resistant vascular prosthesis. Arch Surg 1981; 116: 1403–1407.

87. Moore WS. Lower extremity amputation for peripheral vascular disease. Surgical Rounds 1982; 16–22.

88. Hunter GC, Malone JM, Moore WS, Misiorowski RL, Chvapil M. Vascular manifestations in patients with Ehlers-Danlos syndrome. Arch Surg 1982; 117: 495–498.

89. Malone JM, Moore WS. Cerebrovascular disease in the elderly. Otolaryngologic Clinics of No. America 1982; 15: 405–419.

90. Hunter GC, Sieffert G, Malone JM, Moore WS. The accuracy of carotid artery back pressure as an index for shunt requirements: A reappraisal. Stroke 1982; 13: 319–326.

91. Raviola CA, Nichter L, Baker C, Busuttil RW, Barker WF, Machleder HI, Moore WS. Femoropopliteal tibial bypass: What price failure. Am J Surg 1982; 144: 115–123.

92. Sieffert GF, Weinstein PR, Moore WS. Bilateral extracranial–intracranial bypass before carotid ligation for hemorrhage into a pharyngocutaneous fistula. Surgery 1982; 92: 553–560.

93. Dixon S, Pais SO, Raviola C, Gomes A, Machleder HI, Baker JD, Busuttil RW, Barker WF, Moore WS. Natural history of nonstenotic asymptomatic ulcerative lesions of the carotid artery. Arch Surg 1982; 117: 1493–1498.

94. Moore WS. Vascular surgery. Bulletin, American College of Surgeons 1983; 69: 65–68.

95. Henry RE, Malone JM, Daly MJ, Hughes JH, Moore WS. Skin perfusion measurements: The normal range, the effects of ambient temperature and its clinical application. Proceedings of the Third World Congress of Nuclear Medicine and Biology, Paris, France, Aug 29–Sept 2, 1982. C. Raynaud (Ed). Pergaman Press, 1982.

96. Quiñones-Baldrich W, Moore WS. Extracranial arterial occlusive disease: Natural history, results of medical and surgical therapy. Practical Cardiology 1983; 9: 84–101.

97. Quiñones-Baldrich W, Moore WS. Preventing infection in vascular surgery. Vascular Diagnosis

& Therapy, 1983; 4: 29–35.

98. Busuttil RW, Keehn G, Millikin JA, Paredero VM, Baker JD, Machleder HI, Moore WS, Barker WF. Aortic saddle embolus: A twenty year experience. Ann Surg 1983; 197: 698–706.

(Presented at the 94th Annual Meeting of the Southern Surgical Association, Palm Beach, FL, Dec 6–8, 1982).

99. Salvian A, Baker JD, Machleder HI, Busuttil RW, Barker WF, Moore WS. Cause and noninvasive detection of restenosis after carotid endarterectomy. Am J Surg 1983; 146: 29–34.

100. Moore WS. What’s new in peripheral vascular surgery. J Cardiovasc Surg 1983; 24: 49–52.

101. Moore WS. Vascular prostheses: Infection and prevention. Asepsis 1983; 5: 15–17.

102. Martin-Paredero V, Busuttil RW, Dixon SM, Baker JD, Machleder HI, Moore WS. Fate of aortic graft removal. Am J Surg 1983; 146: 194–197.

103. Martin-Paredero V, Dixon SM, Baker JD, Takiff H, Gomes AS, Busuttil RW, Moore WS. Risk of renal failure after major angiography. Arch Surg 1983; 118: 1417–1420.

104. Gomes AS, Busuttil RW, Baker JD, Oppenheim W, Machleder HI, Moore WS. Congenital arteriovenous malformations—The role of transcatheter arterial embolization. Arch Surg 1983; 118: 817–825.

105. Brown SL, Busuttil RW, Baker JD, Machleder HI, Moore WS, Barker WF. Bacteriologic and surgical determinants of survival in patients with mycotic aneurysms. J Vasc Surg 1984; 1: 542–547.

106. Hiatt JG, Raviola C, Baker JD, Busuttil RW, Machleder HI, Moore WS. The limitations of predictability of success of femoral–popliteal bypass grafts. J Vasc Surg 1984; 1: 617–622.

107. Quiñones-Baldrich WJ, Martin-Paredero V, Baker JD, Busuttil RW, Machleder HI, Moore WS. Polytetrafluoroethylene grafts as the first choice arterial substitute in femoropopliteal revascularization. Arch Surg 1984; 119: 1238–1243.

108. Hiatt JCG, Barker WF, Machleder HI, Baker JD, Busuttil RW, Moore WS. Determinants of failure in the treatment of ruptured abdominal aortic aneurysm. Arch Surg 1984; 119: 1264–1268.

109. Rutherford RB, Jones DN, Bergentz S-E, Bergqvist D, Karmody AM, Dardik H, Moore WS, Goldstone J, Flinn WR, Comerota AJ, Fry WJ, Shah DM. The efficacy of Dextran 40 in preventing early postoperative thrombosis following difficult lower extremity bypass. J Vasc Surg 1984; 1: 765–773.

110. Moore WS. Extra-anatomic bypass for revascularization of occlusive lesions involving the branches of the aortic arch. J Vasc Surg 1985; 2: 230–238.

111. Moore WS. Moderator, Symposium on revascularization after thrombosis of the extracranial vasculature, (pp 228–238); Introduction, (pg 228); Extra-anatomic bypass for revascularization of occlusive lesions involving the branches of the aortic arch, (pp 230–232). J Vasc Surg 1985; 2: 228–232.

112. Quiñones-Baldrich WJ, Moore WS. Intraoperative monitoring and use of the internal shunt during carotid endarterectomy. In Surg 1985; 69: 207–213.

113. Quiñones-Baldrich WJ, Moore WS. Asymptomatic carotid stenosis—Rationale for management. Arch Neurology 1985; 42: 378–382.

114. Gomes AS, Baker JD, Martin-Paredero V, Dixon SM, Takiff H, Machleder HI, Moore WS. Acute renal dysfunction after major arteriography. AJR 1985; 145: 1249–1253.

115. Ziomek S, Quiñones-Baldrich WJ, Busuttil RW, Baker JD, Machleder HI, Moore WS. The superiority of synthetic arterial grafts over autologous veins in carotid–subclavian bypass. J Vasc Surg 1986; 3: 140–145.

116. Quiñones-Baldrich WJ, Moore WS, Ziomek S, Chvapil M. Development of a “leak-proof,” knitted Dacron vascular prosthesis. J Vasc Surg 1986; 3: 895–903.

117. Sheng FC, Quiñones-Baldrich WJ, Machleder HI, Moore WS, Baker JD, Busuttil RW. Relationship of extracranial carotid occlusive disease and central retinal artery occlusion. Am J Surg 1986; 152: 175–178.

118. Ahn SS, Machleder HI, Gupta R, Moore WS. Pathogenesis of peri-graft seroma: Evidence of a humoral fibroblast inhibitor. Surgical Forum, 1986; 37: 460–461.

119. Quiñones-Baldrich WJ, Ziomek S, Henderson TC, Moore WS. Intraoperative fibrinolytic therapy: Experimental evaluation. J Vasc Surg 1986; 4: 229–236.

120. Moore WS. Carotid endarterectomy—Is it safe in the community? J Vasc Surg 1986; 4: 313–314.

121. Quiñones-Baldrich WJ, Ziomek S, Henderson TC, Moore WS. Primary anastomotic bonding in polytetrafluoroethylene grafts? J Vasc Surg 1987; 5: 311–318.

122. Moore WS. Stroke and carotid artery disease: What you can do to prevent them. UCLA Health Insights 1987; 5(3): 1.

123. Hiatt JR, Hiatt JC, Sieffert GF, Moore WS. Effect of endarterectomy on arterial fibrinolytic activator activity. Arch Surg 1987; 122: 712–714.

124. Ahn SS, Machleder HI, Gupta R, Moore WS. Perigraft seroma: Clinical histologic, and serologic correlates. Am J Surg 1987; 154: 173–178.

125. Memsic L, Busuttil RW, Machleder H, Quiñones-Baldrich W, Baker D, Moore WS. Interval gangrene occurring after successful lower-extremity revascularization. Arch Surg 1987; 122: 1060–1063.

126. Sheng FC, Burns R, Baker JD, Machleder HI, Quiñones-Baldrich W, Moore W, Busuttil RW. Determinants of gastrointestinal complications in aortic surgery. Vascular Surgery 1987; 21: 257–264.

127. Skydell JL, Machleder HI, Baker JD, Busuttil RW, Moore WS. Incidence and mechanism of post-carotid endarterectomy hypertension. Arch Surg 1987; 122: 1153–1155.

128. Moore WS. Presidential address: Vascular surgery—A continuing quest for excellence. J Vasc Surg 1988; 7: 185–189.

129. Ahn SS, Auth D, Marcus DR, Moore WS. Removal of focal atheromatous lesions by angioscopically guided high-speed rotary atherectomy—Preliminary experimental observations. J Vasc Surg 1988; 7: 292–300.

130. Moore WS. Does tandem lesion mean tandem risk in patients with carotid artery disease? J Vasc Surg 1988; 7: 454–455.

131. Raviola CA, Nichter LS, Baker JD, Busuttil RW, Machleder HI, Moore WS. Cost of treating advanced leg ischemia: Bypass graft vs primary amputation. Arch Surg 1988; 123: 495–496.

132. Moore WS (Moderator). Round table discussion: Antibiotic prophylaxis in clinical practice. Contemp Surg 1988; 32(3-A): 39–52.

133. Quiñones-Baldrich WJ, Ziomek S, Henderson T, Moore WS. Patency and intimal hyperplasia: The effect of aspirin on small arterial anastomosis. Ann Vasc Surg 1988; 2: 50–56.

134. Ahn SS, Kalunian K, Rosove M, Moore WS. Postoperative thrombotic complications in patients with the lupus anticoagulant: Increased risk after vascular procedures. J Vasc Surg 1988; 7: 749–756.

135. Moore WS, Ziomek S, Quiñones-Baldrich WJ, Machleder HI, Busuttil RW, Baker JD. Can clinical evaluation and noninvasive testing substitute for arteriography in the evaluation of carotid artery disease? Ann Surg 1988; 208: 91–94.

136. Kunkel J, Moore WS. Management errors in the treatment of ruptured abdominal aortic aneurysm. Surgical Rounds 1988; 11: 17–27.

137. Ahn SS, Jordan SE, Nuwer MR, Marcus DR, Moore WS. Computed electroencephalographic topographic brain mapping—A new and accurate monitor of cerebral circulation and function for patients having carotid endarterectomy. J Vasc Surg 1988; 8: 247–54.

138. Quiñones-Baldrich WJ, Freischlag JA, Machleder HI, Busuttil RW, Moore WS. Is the

preferential use of polytetrafluoroethylene grafts for femoropopliteal bypass justified? J Vasc Surg 1988; 8: 219–228.

139. Quiñones-Baldrich WJ, Freischlag JA, Machleder HI, Busuttil RW, Moore WS. Inflow failure of grafts originating in the axillary artery. Ann Vasc Surg 1988; 3: 303–308.

140. Callow AD, Caplan LR, Correll JW, Fields WS, Mohr JP, Moore WS, Robertson JT, Toole JF. Carotid endarterectomy: What is its current status? Am J Med 1988; 85: 835–838.

141. Toole JF, Adams H Jr., Dyken M, Mohr JP, Moore WS, Robertson J. Evaluation for asymptomatic carotid artery atherosclerosis: A multidisciplinary consensus statement. Southern Med J 1988; 81: 1549–1552.

142. Beebe HG, Clagett GP, DeWeese JA, Moore WS, Robertson JT, Sandok B, Wolf PA. Assessing risk associated with carotid endarterectomy. Stroke 1989; 20: 314–315.

142a.Beebe HG, Clagett GP, DeWeese JA, Moore WS, Robertson JT, Sandok B, Wolf PA. Assessing risk associated with carotid endarterectomy. Circulation 1989; 79: 472–473.

143. Moore WS. Shunting during carotid endarterectomy: Always, never, sometimes? Seminars in Vasc Surg 1989; 2: 28–34.

144. Ahn SS, Marcus DR, Moore WS. Post-carotid endarterectomy hypertension: Association with elevated cranial norepinephrine. J Vasc Surg 1989; 9: 351–360.

145. Beebe HG, Clagett GP, DeWeese JA, Moore WS, Robertson JT, Sandok B, Wolf PA. Assessing risk associated with carotid endarterectomy. Special Report, American Heart Association 1989, pp 472–473.

146. Chervu A, Moore WS, Homsher E, Quiñones-Baldrich WJ. Differential recovery of skeletal muscle and peripheral nerve function after ischemia and reperfusion. J Surg Research 1989; 47: 12–19.

147. Chervu A, Moore WS, Quiñones-Baldrich WJ, Henderson T. Efficacy of corticosteroids in suppression of intimal hyperplasia. J Vasc Surg 1989; 10: 129–134.

148. The Asymptomatic Carotid Atherosclerosis Study Group. Study design for randomized prospective trial of carotid endarterectomy for asymptomatic atherosclerosis. Stroke 1989; 20: 844–849.

149. Quiñones-Baldrich WJ, Baker JD, Busuttil RW, Machleder HI, Moore WS. Intraoperative infusion of lytic drugs for thrombotic complications of revascularization. J Vasc Surg 1989; 10: 408–417.

150. Moore WS, Treiman RL, Hertzer NR, Veith FJ, Perry MO, Ernst CB, Ad Hoc Committee to the Joint Council for the Society of Vascular Surgery and the North American Chapter of the International Society of Vascular Surgery. Guidelines for hospital privileges in vascular surgery. J Vasc Surg 1989; 10: 678–672.

151. Gelabert HA, Moore WS. Carotid endarterectomy without angiography. Surg Clinics of N Am 1990; 70: 213–223.

152. Gupta SK, Veith FJ; with collaboration of Kossoff A, Sochalski J, Shipe G, Bernhard VM, Brener BJ, Devine J, Bernstein EF, Dilley RB, Hertzer NR, Leather RP, Shah DM, Moore WS, String ST, Towne JB, Whittemore AD, Mannick JA. Inadequacy of diagnosis related group (DRG) reimbursements for limb salvage lower extremity arterial reconstructions. J Vasc Surg 1990; 11: 348–357.

153. Moore WS. Diagnosis and management of patients with asymptomatic carotid artery bruit. Comprehensive Therapy 1990; 16: 46–50.

153a.Gelabert HA, Moore WS. Carotid surgery without arteriography. Surg Clin N Am 1990; 56: 263–267.

154. Strichartz SE, Gelabert HA, Moore WS. Retrograde aortic dissection with bilateral renal artery occlusion after repair of infrarenal aortic aneurysm. J Vasc Surg 1990; 12: 56–59.

155. Freischlag JA, Moore WS. Clinical experience with a collagen-impregnated knitted Dacron vascular graft. Ann Vasc Surg 1990; 4: 449–454.

156. Moore WS, Martello JY, Quiñones WJ, Ahn SS. Etiologic importance of the intimal flap in the development of postcarotid endarterectomy stroke. Stroke 1990; 21: 1497–1502.

157. Chervu A, Moore WS. An overview of intimal hyperplasia. Surg Gynecol Obstet 1990; 171: 433–447.

158. Ahn SS, Arca MJ, Marcus DR, Moore WS. Histologic and morphologic effects of rotary atherectomy on human cadaver arteries. Ann Vasc Surg 1990; 4: 563–569.

159. Moore WS. Therapeutic options for femoropopliteal occlusive disease. Circulation Supp I 1991; 83(2): I-91–I-93.

160. Brewster DC, Moore WS, Ernst CB, Bernhard VM. Late Graft Infection Following Aortofemoral Bypass. Perspectives in Vasc Surg 1990; 3: 61–78.

161. Quiñones-Baldrich WJ, Prego A, Ucelay-Gomez R, Vescera CL, Moore WS. Failure of PTFE Infrainguinal Revascularization: Patterns, Management Alternatives, and Outcome. Ann Vasc Surg 1991; 5: 163–169.

162. Moore WS. Quality assurance and hospital privileges in vascular surgery. J Vasc Surg 1990; 13: 520.

163. Moore WS. Guidelines for hospital privileges in vascular surgery. J Vasc Surg 1990; 13: 527–531.

164. Quiñones-Baldrich WJ, Hernandez JJ, Moore WS. Long-term results following surgical management of aortic graft infection. Arch Surg 1991; 126: 507–511.

165. Ahn SS, Blaha CD, Alkire MT, Wood E, Gray-Allan P, Marrocco RT, Moore WS. Biphasic striatal dopamine release during transient ischemia and reperfusion in gerbils. Stroke 1991; 22: 674–679.

166. Chervu A, Moore WS, Chvapil M, Henderson T. Efficacy and duration of antistaphylococcal activity comparing three antibiotics bonded to Dacron vascular grafts with a collagen release system. J Vasc Surg 1991; 13: 897–901.

167. Ahn SS, Baker JD, Walden K, Moore WS. Which asymptomatic patients should undergo routine screening carotid duplex scan? Am J Surg 1991; 162: 180–184.

167a.Eton D, Ahn SS, Baker JD, Pensabene J, Yeatman LS, Moore WS. Intraoperative endovascular ultrasonography. Proc SPIE 1991; 1425: 182–187.

168. Quiñones-Baldrich WJ, Chervu A, Hernandez JJ, Colburn M, Moore WS. Skeletal muscle function after ischemia: “No reflow” versus reperfusion injury. J Surg Res 1991; 51: 5–12.

169. Gelabert HG, Moore WS. Reducing the risk of stroke: Identifying patients to refer for carotid endarterectomy. Geriatrics 1991; 46: 22–26.

170. Colburn MD, Moore WS. Pathology, natural history, and treatment of cerebrovascular disease. Current Opinion in Cardiology 1991; 6: 757–761.

171. Chervu A, Moore WS, Gelabert HA, Colburn MD, Chvapil M. Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system. J Vasc Surg 1991; 14: 521–525.

172. Moore WS, Vescera CL, Robertson JT, Baker WH, Howard VJ, Toole JT. Selection process for surgeons in the Asymptomatic Carotid Artery Stenosis Study. Stroke 1991; 22: 1353–1357.

172a.Ahn SS; Baker JD; Moore WS: Carotid Endarterectomy Based on Duplex Scanning Without Routine Angiography. Perspectives in Vasc Surg 1991; 4: 109–120.

173. Colburn MD, Moore WS, Gelabert HA, Quiñones-Baldrich WJ. Dose responsive suppression of myointimal hyperplasia by dexamethasone. J Vasc Surg 1992; 15: 510–518.

174. Moore WS, Mohr JP, Najafi H, Robertson JT, Stoney RJ, Toole JF. Carotid endarterectomy: Practice guidelines — Report of the Ad Hoc Committee to the Joint Council of the Society for Vascular Surgery and the North American Chapter of the International Society for Cardiovascular Surgery. J Vasc Surg 1992; 15: 469–479.

175. Freischlag JA, Hanna D, Moore WS. Improved prognosis for asymptomatic carotid stenosis with prophylactic carotid endarterectomy. Stroke 1992; 23: 479–482.

176. Moore WS. Steps to technical expertise in carotid endarterectomy. Surgical Technology International 1991; 1: 163–165.

177. Colburn MD, Quiñones-Baldrich WJ, Gelabert HA, Nowara H, Moore WS. Standardization of skeletal muscle ischemic injury. J Surg Res 1992; 52: 309–313.

178. Ahn SS, Eton D, Yeatman LR, Deutsch L-S, Moore WS. Intraoperative peripheral rotary atherectomy: Early and late clinical results. Ann Vasc Surg 1992; 6: 272–280.

179. Freischlag JA, Colburn MD, Quiñones-Baldrich WJ, Moore WS. Alteration of neutrophil (PMN) function by heparin, dexamethasone, and enalapril. J Surg Res 1992; 52: 523–529.

180. Ahn SS, Eton D, Moore WS. Endovascular surgery for peripheral arterial disease: A critical review. Surg 1992; 216: 3–16.

181. Quiñones-Baldrich WJ, Prego AA, Ucelay-Gomez R, Freischlag JA, Ahn SS, Baker JD, Machleder HI, Moore WS. Long-term results of infrainguinal reaction with polytetrafluoroethylene: A ten-year experience. J Vasc Surg 1992; 16: 209–217.

182. Freischlag JA, Colburn MD, Quiñones-Baldrich WJ, Moore WS. Heparin, urokinase, and ancrod alter neutrophil function. J Vasc Surg 1992; 16: 525–574.

183. Colburn MD, Moore WS, Chvapil M, Gelabert HA, Quiñones-Baldrich WJ. Use of an antibiotic- bonded graft for in situ reconstruction after prosthetic graft infections. J Vasc Surg 1992; 16: 651–660.

184. Eton D, Colburn MD, Shin V, Panek W, Lee D, Moore WS, Ahn SS. Inhibition of intimal hyperplasia by photodynamic therapy using photofrin. J Surg Res 1992; 53: 558–562.

185. Hobson RW II, Weiss DG, Fields WS, Goldstone J, Moore WS, Towne JB, Wright CB, and the Veterans Affairs Cooperative Study Group. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 1993; 328: 221–227.

186. Abbott WM, Callow A, Moore W, Rutherford R, Veith F, Weinberg. Evaluation and performance standards for arterial prostheses. J Vasc Surg 1993; 17: 746–756.

187. Moore WS. Carotid endarterectomy for prevention of stroke. West J Med 1993; 159: 37–43.

188. Sarkar R, Moore WS. Management of asymptomatic carotid stenosis. Surgical Rounds 1993; 16: 597–603.

189. Perry MO, DeWeese JA, Goldstone J, Moore WS, Whittemore AD. Carotid endarterectomy and perioperative stroke. Perspectives in Vasc Surg 1993; 6: 15–28.

190. Quiñones-Baldrich WJ, Colburn MD, Ahn SS, Gelabert HA, Moore WS. Very distal bypass for salvage of the severely ischemic extremity. Am J Surg 166: 117–123 (1993).

191. Colburn MD, Moore WS. Buerger’s disease. Heart Disease and Stroke. 1993; 2: 424–432.

192. McCrory DC, Goldstein LB, Samsa GP, Oddone EZ, Landsman PB, Moore WS, Matchar DB. Predicting complications of carotid endarterectomy. Stroke 1993; 24: 1285–1291.

193. Makhoul RG, Moore WS, Colburn MD, Quiñones-Baldrich WJ, Vescera CL. Benefit of carotid endarterectomy after prior stroke. J Vasc Surg 1993; 18: 666–671.

193a.Eton D, Ahn SS, Kitada S, Lee DA, Shim VC, Moore WS. Pitfalls in the evaluation of photosensitizing agents: An example with Q-switch II dye. Laryngoscope 1993; 103: 1284–1290.

193b.Ahn SS, Moore WS, Kaiura TL, Shickman M. Endovascular training model for continuing medical education course. J Continuing Education in Health Professions 1993; 13: 215–221.

194. Colburn MD, Gelabert HA, Nowara H, Hajjar GE, Moore WS, Quiñones-Baldrich WJ. The effect of hypofibrinogenemia and fibrinolysis on skeletal muscle function after ischemia and reperfusion. J Surg Res 1994; 56: 77–81.

195. Law MM, Colburn MD, Hajjar GE, Gelabert HA, Quiñones-Baldrich WJ, Moore WS. Suppression of intimal hyperplasia in a rabbit model of arterial balloon injury by enalaprilat but not dimethyl sulfoxide. Ann Vasc Surg 1994; 8: 158–165.

196. Law MM, Gelabert HA, Colburn MD, Quiñones-Baldrich WJ, Ahn SS, Moore WS. Continuous postoperative intra-arterial urokinase infusion in the treatment of no reflow following revascularization of the acutely ischemic limb. Ann Vasc Surg 1994 8: 66–73.

197. Chervu A, Moore WS. Carotid endarterectomy without arteriography. Ann Vasc Surg 1994; 8: 296–302.

198. Gelabert HA, El-Massry S, Moore WS. Carotid endarterectomy with primary closure does not adversely affect the rate of recurrent stenosis. Arch Surg 1994; 129: 648–654.

199. Ahn SS, Mehigan JT, Gupta SK, Veith FJ, Mitchell RS, Moore WS and the Collaborative Rotablator Atherectomy Group (CRAG). Peripheral atherectomy with the rotablator: A multicenter report. J Vasc Surg 1994; 19: 509–515.

200. Moore WS, Machleder HI, Porter JM, Roos, DB. Symposium — Thoracic outlet syndrome. Contemp Surg 1994; 45: 99–111.

201. Feinberg WM, Albers GW, Barnett HJM, Biller J, Caplan LR, Carter LP, Hart RG, Hobson RW II, Kronmal RA, Moore WS, Robertson JR, Adams HP, Mayberg M. Guidelines for the management of transient ischemic attacks — From the Ad Hoc Committee on Guidelines for the Management

of Transient Ischemic Attacks of the Stroke Council of the American Heart Association. Stroke 1994; 25: 1320–1335.

202. Quiñones-Baldrich WJ, Colburn MD, Gelabert HA, Barcliff LT, Moore WS. Isolated limb thrombolysis with Extracorporeal pump and urokinase. J Surg Res 1994; 57: 344–351.

203. Moore WS, Vescera CL. Repair of abdominal aortic aneurysm by transfemoral endovascular graft placement. Ann Surg 1994; 220: 331–341.

204. Colburn MD, Moore WS. Reoperative approach for failed aortofemoral, axillofemoral, and femorofemoral bypasses. Sem Vasc Surg 1994; 7: 139–151.

205. Weinstein ES, McIntyre KE, Moore WS, Olcott C IV. Management of an external iliac artery aneurysm. Perspectives in Vasc Surg 1994; 7: 35–415.

206. Ahn SS, Machleder HI, Concepcion B, Moore WS. Thoracoscopic cervicodorsal sympathectomy: Preliminary results. J Vasc Surg 1994; 20: 511–519.

207. See item 25a.

208. See item 142a.

209. See item 167a.

210. See item 172a.

211. See item 193a.

212. See item 193b.

213. Moore WS, Barnett HJM, Beebe HG, Bernstein ER, Brener BJ, Brott T, Caplan LR, Day A, Goldstone J, Hobson RW II, Kempczinski RF, Matchar DB, Mayberg MR, Nicolaides AN, Norris JW, Ricotta JJ, Robertson JT, Rutherford RB, Thomas D, Toole JF, Trout HH III, Wiebers DO. Guidelines for carotid endarterectomy — A multidisciplinary consensus statement from the ad hoc committee, American Heart Association. Stroke 1995; 26: 188–201.

214. Moore WS, Barnett HJM, Beebe HG, Bernstein ER, Brener BJ, Brott T, Caplan LR, Day A, Goldstone J, Hobson RW II, Kempczinski RF, Matchar DB, Mayberg MR, Nicolaides AN, Norris JW, Ricotta JJ, Robertson JT, Rutherford RB, Thomas D, Toole JF, Trout HH III, Wiebers DO. Guidelines for carotid endarterectomy — A multidisciplinary consensus statement from the ad hoc committee, American Heart Association. Circulation 1995; 91: 566–579.

215. Moore WS. The American Heart Association consensus statement on guidelines for carotid endarterectomy. Seminars in Vasc Surg 1995; 8: 77–81

216. Consensus Group: Nicolaides AN, Barnett HJM, Belcaro GV, Bernstein EF, Callow A, Eastcott HHG, Eikelboom B, Eklof B, Geroulakos G, Halliday A, Hobson R, Kalodiki E, Lusby R, Malikides A, Middleton LT, Moore WS, Norris J, Prescott L, Ramaswami G, Rutherford R, Sandmann W, Shanik G, Spartera C, Thomas D. Consensus statement on the management of patients with asymptomatic atherosclerotic carotid bifurcation lesions. International Angiology 1995; 14: 5–17

217. Moore WS. Controversies in the Management of Carotid Stenosis: Carotid Endarterectomy vs. Aspirin — Proceedings of the Japanese Congress of Neurological Surgeons, Sendai, Japan. Neurosurgeons 1995; 14: 65–71.

218. Veith FJ, Abbott WM, Yao JST, Goldstone J, White RA, Abel D, Dake MD, Ernst CB, Fogarty TJ, Johnston KW, Moore WS, van Breda A, Sopko G, Didisheim P, Rutherford RB, Katzen BT, Miller DC, for the Endovascular Graft Committee. Guidelines for development and use of transluminally placed endovascular prosthetic grafts in the arterial system. J Vasc Surg 1995; 21: 670–685.

219. Moore WS. The role of endovascular grafting technique in the treatment of infrarenal abdominal aortic aneurysm. Cardiovascular Surgery 1995; 3: 109–114.

220. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273: 1421–1428.

221. Petrik PV, Gelabert HA, Moore WS, Quiñones-Baldrich W, Law MM. Cigarette smoking accelerates carotid artery intimal hyperplasia in a dose-dependent manner. Stroke 1995; 26: 1409–1414.

222. Ahn SS, Gray-Allan P, Wood ER, Ghalili SS, Moore WS, Blaha CD. Correlation of striatal dopamine release and peripheral hypertension after transient ischemia in gerbils. J Vasc Surg 1995; 22: 135–141.

223. Law MM, Colburn MD, Moore WS, Quiñones-Baldrich WJ, Machleder HI, Gelabert HA. Carotid–subclavian bypass for brachiocephalic occlusive disease—choice of conduit and long-term follow-up. Stroke 1995; 26: 1565–1571.

224. Petrik PV, Law MM, Moore WS, Colburn MD, Quiñones-Baldrich WJ, Gelabert HA. Pharmacologic suppression of intimal hyperplasia: A dose-response suppression by Enalapril. The American Surgeon 1995; 61: 851–855.

225. Quiñones-Baldrich WJ, Deaton DH, Mitchell RS, Berry G, Piplani A, Quiachon D, Edwards WH, Moore WS. Preliminary experience with the Endovascular Technologies bifurcated endovascular aortic prosthesis in a calf model. J Vasc Surg 1995; 22: 370–381.

226. Ahn SS, Clem MF, Braithwaite BD, Concepcion B, Petrik PV, Moore WS. Laparoscopic aortofemoral bypass—Initial experience in an animal model. Ann Surg 1995; 222: 677–683.

227. Ahn SS, Moore WS. Development of endovascular surgery: Experience at UCLA, 1985–1990. Asian J. Surgery 1996; 19: 11–18.

228. Stanley JC, Barnes RW, Ernst CB, Hertzer NR, Mannick JA, Moore WS. Vascular surgery in the United States: Workforce issues. Report of the Society for Vascular Surgery and the International Society for Cardiovascular Surgery, North American Chapter, Committee on Workforce Issues. J Vasc Surg 1996; 23: 172–181.

229. Moore WS, Young B, Baker WH, Robertson JT, Toole JF, Vescera CL, Howard VJ, and the ACAS Investigators. Surgical results: A justification of the surgeon selection process for the ACAS trial. J Vasc Surg 1996; 23: 323–328.

230. Beebe HG, Archie JP, Baker WH, Barnes RW, Becker GJ, Bernstein EF, Brener B, Clagett GP, Clowes AW, Cooke JP, Creager MA, Cronenwett JL, Dake M, DeWeese JA, Fogarty TJ, Freischlag JA, Goldstone J, Greenfield LJ, Hertzer NR, Hobson RW, Joyce JW, Katzen BT, LoGerfo FW, Mohr JP, Moore WS, Najafi H, Ricotta JJ, Riles TS, Ring EJ, Robertson J, Rutherford RB, Sos T, Stanley JC, Strandness DE, Sumner DS, Toole J, Towne JB, Veith FJ, Whittemore AD, Yao JST, Zarins CK. Concern about safety of carotid angioplasty. Stroke 1996; 27: 197–198.

231. Petrik PV, Gelabert HA, Moore WS, Quiñones-Baldrich WJ. The effect of vitamin E and doxycycline on the development of intimal hyperplasia. J Surg Res 1996; 60: 279–283.

232. Law MM, Gelabert HA, Moore WS, Hajjar GE, Colburn MD, Petrik PV, Quiñones-Baldrich WJ. Cigarette smoking increases the development of intimal hyperplasia after vascular injury. J Vasc Surg 1996; 23: 401–409.

233. Moore WS, Rutherford RB, for the EVT Investigators. Transfemoral endovascular repair of abdominal aortic aneurysm: Results of the North American EVT phase 1 trial. J Vasc Surg 1996; 23: 543–553.

234. Moore WS. Transfemoral endovascular repair of abdominal aortic aneurysm. Journal of the Irish Colleges of Physicians and Surgeons, 1996; 25: 104–109.

235. Moore WS, Clagett GP, Hobson RW II, Towne JB, Veith FJ. Vision of optimal vascular surgical training in the next two decades: Strategies for adapting to new technologies. J Vasc Surg 1996; 23: 926–931.

236. Colburn MD, Moore WS. Endovascular repair of abdominal aortic aneurysms using the EGS tube and bifurcated graft system. World J Surg 1996; 20: 664–672.

237. Moore WS. World Progress in Surgery. Endovascular surgery: State of the art—Introduction. World J Surg 1996; 20: 621, 1996.

238. Young B, Moore WS, Robertson JT, Toole JF, Ernst CB, Cohen SN, Broderick JP, Dempsey RJ, Hosking JD. An analysis of perioperative surgical mortality and morbidity in the Asymptomatic Carotid Atherosclerosis Study. Stroke 1996; 27: 2216–2224.

239. Ahn SS, Curtis BV, Marcus DR, Askar H, Quiñones-Baldrich W, Machleder HI, Baker JD, Walden K, Moore WS. Intraoperative vascular endoscopy: Early and late results. Ann Vasc Surg 1996; 10: 443–451.

239a.Braithwaite B, Petrik P, Moore W, Gelabert H, Pollen D, Earnshaw J, Quiñones-Baldrich W. Aspirin increases tissue edema after skeletal muscle ischemia and reperfusion. Eur J Vasc Endovasc Surg 1996; 12: 76–80.

240. Ahn SS, Rutherford RB, Johnston KW, May J, Veith FJ, Baker JD, Ernst CB, Moore WS, for the Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery of The Society for Vascular Surgery/International Society for Cardiovascular Surgery. Reporting standards for infrarenal endovascular abdominal aortic aneurysm repair. J Vasc Surg 1997; 25: 405–410.

241. Moore WS, for the EVT Investigators. The EVT Tube and Bifurcated Endograft Systems: Technical Considerations and Clinical Summary. J Endovasc Surg 1997; 4: 182–194.

242. Quiñones-Baldrich WJ, Nene SM, Gelabert HA, Moore WS: Rupture of the perivisceral aorta: Atherosclerotic versus mycotic aneurysm. Ann Vasc Surg 1997; 11: 331–341.

243. Gelabert HA, Colburn MD, Moore WS. Use of the in-situ lesser saphenous vein bypass from popliteal to peroneal artery. Ann Vasc Surg 1997; 11: 378–382.

244. Nene SN, Gelabert HA, Moore WS, Quiñones-Baldrich WJ. Thrombus diminishes endothelial- dependent relaxation in the rabbit carotid artery. Surgical Forum 1997; XLVIII.

244a.Nene S, Gelabert H, Moore W, Quiñones-Baldrich W, Santibanez-Gallerani A, Henderson T, Byrns R, Hobbs A, Ignarro L. Cigarette smoking increases endothelial derived vasorelaxation in the rat carotid artery in a dose dependent manner. J Surg Res 1997: 71: 101–106.

244b. Ahn SS, Obrand DI, Moore WS. Transluminal Balloon Angioplasty, Stents and Atherectomy.

Seminars in Vasc Surg, 1997.

245. See 239a.

246. Petrik P, Braithwaite B, Gelabert H, Moore W, Quiñones-Baldrich W. Pentoxifylline improves skeletal muscle recovery after acute ischemic and reperfusion injury. Vascular Surgery 1998; 32: 5–12.

247. Matsumura JS, Moore WS, for the Endovascular Technologies Investigators. Clinical consequences of periprosthetic leak after endovascular repair of abdominal aortic aneurysm. J Vasc Surg 1998; 27: 606–613.

248. See 244a.

249. Petrik P, Law M, Moore WS, Colburn M, Quiñones-Baldrich W, Gelabert H. Dexamethasone and enalapril suppress intimal hyperplasia individually but not synergistically. Ann Vasc Surg 1998; 12: 216–220.

250. See 244b.

251. Moore WS, Kempczinski RF, Nelson JJ, Toole JF, for the ACAS Investigators. Recurrent carotid stenosis—Results of the Asymptomatic Carotid Atherosclerosis Study. Stroke 1998; 29: 2018–2025.

251a.Nene S, Gelabert HA, Moore WS, Quiñones-Baldrich WJ, Henderson TC. Exposure to thrombus diminished endothelial derived relaxation in the rabbit carotid artery. J Surg Res 1999; 87: 51-56.

252. Kashyap VS, Moore WS, Quiñones-Baldrich WJ. Carotid artery repair for radiation-associated atherosclerosis is a safe and durable procedure. J Vasc Surg 1999; 29: 90–99.

253. Nene S, Moore WS. The role of patch angioplasty in prevention of early recurrent carotid stenosis. Ann Vasc Surg 1999; 13: 169–173.

253a. Nene S, Moore WS. Place de l’angioplastie par patch dans la prévention des resténoses carotidiennes précoces. Ann chir Vasc 1999; 13: 169-173.

254. Sarkar R, Moore WS, Quiñones-Baldrich WJ, Gomes, AS. Endovascular repair of abdominal aortic aneurysm using the EVT device: Limited increased utilization with availability of a bifurcated graft. J Endovasc Surg 1999; 6: 131-135.

255. Moore WS, Kashyap VS, Vescera CL, Quiñones-Baldrich WJ. Abdominal aortic aneurysm: A 6- year comparison of endovascular versus transabdominal repair. Ann Surg 1999; 230: 298-308.

256. See 251a.

257. Reil TD, Moore WS, Kashyap VS, Nene SS, Gelabert HA, Quiñones-Baldrich WJ. The effects of thrombus, thrombectomy and thrombolysis on endothelial function. Eur J Vasc Endovasc Surg 2000; 19: 162-168.

258. Moore, WS. A narrow-wasted aortic aneurysm need not hinder endovascular graft repair. J Endovasc Ther 2000; 7: 203.

259. Angle N, Moore W. Carotid endarterectomy without preoperative angiography. Acta Chirurgica Belgica 2000; issue 5.

260. Moore WS, Brewster DC, Bernhard VM. Aorto-uni-iliac endograft for complex aortoiliac aneurysms compared with tube/bifurcation endografts: Results of the EVT/Guidant trials. J Vasc Surg 2001; 33: S11-20.

261. Petrik PV, Moore WS. Endoleaks following endovascular repair of abdominal aortic aneurysm: The predictive value of preoperative anatomic factors—a review of 100 cases. J Vasc Surg 2001; 33: 739-744.

262. Pross C, Shortsleeve CM, Baker JD, Sicklick JK, Farooq MM, Moore WS, Quiñones-Baldrich WJ, Ahn SS, Gelabert HA, Freischlag JA. Carotid endarterectomy with normal findings from a completion study: Is there need for early duplex scan? J Vasc Surg 2001; 33: 963-967.

263. Kashyap VS, Ahn SS, Petrik PV, Moore WS. Current training and practice of endovascular surgery: A survey. Ann Vasc Surg 2001; 15: 294-305.

264. Farooq, MM, Reil, TR, Gelabert, HA, Ahn, SS, Baker, JD, Moore, WS, Quinones, WJ, Freischlag, JA: Combined carotid endarterectomy and coronary bypass: A decade experience at UCLA. Cardiovascular Surgery 2001; 9: 339.

265. Kashyap VS, Ahn SS, Petrik PV, Moore WS. Apprentissage et pratique actuels de la chirurgie endovasculaire: Résultats d’une enquête. Ann Chir Vasc 2001; 15: 294-305.

265a Kashyap VS, Reil TD, Moore WS, Hoang TX, Gelabert HA, Byrns RE, Ignarro LJ, Freischlag MD. Acute arterial thrombosis causes endothelial dysfunction: A new paradigm for thrombolytic therapy. J Vasc Surg 2001; 34: 323-329.

266. Reil T, Shekherdimian S, Gelchet P. Moore W. The safety of carotid endarterectomy in patients with preoperative renal dysfunction. Ann Vasc Surg 2002; 16: 176-180.

267. Kashyap VS, Ahn SS, Quiñones-Baldrich WJ, Choi B-U, Dorey F, Reil TD, Freischlag JA, Moore WS. Infrapopliteal-lower extremity revascularization with prosthetic conduit: A 20-year experience. Vasc Endovasc Surg 2002, 36: T1-T8.

268. Kashyap VS, Ahn, SS, Davis MR, Moore, WS, Diethrich EB. Trends in endovascular surgery training. J Endovasc Ther 2002; 9: 633-638.

269. Moore WS, Clagett GP, Veith FJ, Moneta GL, Webster MW, Stanley JC, Ouriel K, Andros G, Calligaro KD, Kent, KC. Guidelines for hospital privileges in vascular surgery: An update by an ad hoc committee of the American Association for Vascular Surgery and the Society for Vascular Surgery. J Vasc Surg 2002; 36: 1276-1282.

270. Angle N, Dorafshar AH, Farooq MM, Ahn SS, Gelabert HA, Quiñones-Baldrich WJ, Moore WS, Freischlag JA. The evolution of the axillofemoral bypass over two decades. Ann Vasc Surg 2002; 16: 742-745.

271. Lane JS, Shekherdimian S, Moore WS. Does female gender or hormone replacement therapy affect early or late outcome after carotid endarterectomy? J Vasc Surg 2003; 37: 568-574.

272. Moore WS. The Guidant Ancure bifurcation endograft: Five-year follow-up. Seminars in Vascular Surgery, 2003; 16: 139-143.

273. Moore W, Matsumura JS, Makaroun MS, Katzen BT, Deaton DH, Decker M, Walker G, and EVT/Guidant Investigators. Five-year interim comparison of the Guidant bifurcated endograft with open repair of abdominal aortic aneurysm. J Vasc Surg 2003; 38: 46-55.

274. Moore WS. For severe carotid stenosis found on ultrasound, further arterial evaluation is unnecessary. Stroke 2003; 34: 1816-1817.

275. Moore WS. Resolved: NASCET and ACAS need not be repeated – The affirmative position. Arch Neurol 2003; 60: 775-778.

276. Rigberg DA, Dorafshar A, Sridhar A, Quiñones-Baldrich W, Moore WS. Abdominal aortic aneurysm – Stent graft vs clinical pathway for direct retroperitoneal repair. Arch Surg 2004; 139: 941-946.

277. Angle N, Dorafshar AH, Moore WS, Quiñones-Baldrich WJ, Gelabert HA, Ahn SS, Baker JD. Open versus endovascular repair of abdominal aortic aneurysms: What does each really cost? Ann Vasc Surg. 2004; 18:612-618.

278. Hobson RW, Howard VJ, Roubin GS, Ferguson RD, Brott TG, Howard G, Sheffet AJ, Roberts J, Hopkins LN, Moore WS. Credentialing of surgeons as interventionalists for carotid artery stenting: Experience from the lead-in phase of CREST. J Vasc Surg 2004; 40: 952-957.

279. Dorafshar AH, Reil TD, Moore WS, Quiñones-Baldrich WJ, Angle N, Fahoomand F, Ahn SS, Gelabert HA, Baker JD, Freischlag JA. Cost analysis of carotid endarterectomy: Is age a factor? Ann Vasc Surg 2004; 18: 729-735.

280. See 253a.

281. Moore WS. Commentary on MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurologic symptoms: Randomized controlled trial. [from Lancet 2004; 363: 1491- 1502.] Pers Vasc Surg Endovasc Ther 2005; 17: 62-63.

282. Shifrin EG, Moore WS, Bell PRF, Kolvenbach R, Daniline EI: Intravascular stapler for “open” aortic surgery: Preliminary results. Eur J Vasc Endovasc Surg 2006 doi: 10.1016/j.ejvs 2006: 10: 019.

283. Beseth BD, Moore WS. The posterior approach for repair of popliteal artery aneurysms. J: Vasc Surg 2006; 43: 940-5.

284. Shifrin EG, Moore WS, Bell PRF, Kolvenbach R, Daniline EI. Intravascular stapler for “open” aortic surgery: Preliminary results. Eur J Vasc Endovasc Surg 2007; 33: 408-411.

285. See 265a.

286. Biggs KL, Moore WS. Current Trends in Managing Carotid Artery Disease. Surg Clin N Am 2007; 87: 995-1016.

287. Jimenez JC, Moore WS, Quiñones-Baldrich WJ. Acute and chronic open conversion after endovascular aortic aneurysm repair: A 14-year review. J Vasc Surg 2007; 46: 642-647.

288. Dorafsher AH, Reil TD, Ahn SS, Quiñones-Baldrich WJ, Moore WS. Interposition grafts for difficult carotid artery reconstruction: A 17-year experience. Ann Vasc Surg 2008; 22: 63-69.

289. Jimenez JC, Moore WS, Lawrence PF, Quiñones-Baldrich WJ. Technical strategies for recurrent carotid stenosis following angioplasty and stenting. Ann Vasc Surg 2008; 22:179-184.

290. Jimenez JC, Moore WS. A staged replacement of the entire aorta from the ascending arch to the hypogastric arteries using a hybrid approach. J Vasc Surg 2008; 48:1593-1596.

291. Quinones-Baldrich WJ, Jimenez JC, DeRubertis B, Moore WS. Combined endovascular and surgical approach (CESA) to thoracoabdominal aortic pathology: A 10-year experience. J Vasc Surg 2009; 49:1125-1134

292. Sheffet AJ, Roubin G, Howard G, Howard V, Moore WS, Meschia JF, Hobson RW, II1+, Brott TG. Design of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST). In: Journal of Stroke Vol. 5 February 2010, 40-46

293. Moore WS. Carotid Endarterectomy versus Carotid Angioplasty Cui Bono. Eur J Endovas Surg 2010; 39, 44-48

294. Chandra A, O’Connell J, Quinones-Baldrich WJ, Lawrence PF, Moore WS, Gelabert HA, Jimenez JC. Aneurysmectomy with Arterial Reconstruction of Renal Artery Aneurysms in The Endovascular Era: A Safe, Effective Treatment for Both Aneurysm and Associated Hypertension. In: Ann Vasc Surg 2010; 24; 503-510

295. Brott TG, Hobson RW, Howard G, Moore WS, et al. In: Stenting versus Endarterectomy for

Treatment of Carotid-Artery Stenosis. N. Engl J Med July 1 2010, 363:11-23

296. Tulloch AW, Jimenez JC, Lawrence PF, Dutson EP, Moore WS, Rigberg DA, DeRubertis BG, Quinones WJ. Laparoscopic Versus Open Celiac Ganglionectomy in Patients with Median Arcuate Ligament Syndrome In: Journal of Vascular Surgery November 2010; 52, 1283 – 1300

297. Abbara S, Bacharach MJ, Barr JB, Bush RL, Cates CU, Creager MA, Fowler SB, Friday G, Hertzberg VS, McIff EB, Moore WS et al. In:

Guideline on the Management of Patients with Extracranial Carotid and Vertebral Artery Disease.

J. Am Coll. Cardoil. Published online January 31 2011, No XX, 2011

298. Silver FL, Mackey A, Clark WM, Brooks W, Timaran CH, David C, Goldstein LB, Meschia JF, Ferguson RD, Moore WS, Howard G, Brott TG. Safety of Stenting and Endarterectomy by Symptomatic Status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke 2011;42;675-680; originally published online Feb 9, 2011

299. Paraslevas KI, Mikhailidis DP, Moore WS. Optimal Contemporary Management of Symptomatic and Asymptomatic Carotid Artery Stenosis. Vascular, Vol. 19 No.3, pp. 117-120, 2011 Royal Society of Medicine Press.

300. Paraskevas KI, Veith FJ, Riles TS, Moore WS. Is Carotid Artery Stenting A Fair Alternative to Carotid Endarterectomy for Symptomatic Carotid Artery Stenosis? A Commentary on

the AHA/ASA Guidelines. J Vasc Surg 2011; 54:541-3

301. Lew W, Moore WS. Antibiotic – Impregnated Grafts for Aortic Reconstruction. Semin Vasc Surg 24:211-219, 2011.

302. Mohr JP, Moore WS, Kejda-Scharler J. Carotid Artery Disease and Interventional Therapy. Curr Opin Neurol 2012, 25:36 -41

303. Farley SM, Rigberg D, Jimenez, JC, Moore WS, Quinones-Baldrich, WJ. A Retrospective Stenting of the Aortic Neck for Endovascular Aneurysm Repair. Ann Vasc Surg 2011;25:735- 739

304. Lal BK, Roubin GS, Lutsep HL, Moore WS, et al. In: Restenosis after carotid artery stenting and endarterectomy: A secondary analysis of CREST, a randomized controlled trial. The Lancet. Published on-line August 2, 2012. http://dx.doi.org/10.1016/S1474-4422(12)70159-X

305. Goldsteon, LB, Bushell, CD, Adams, RJ, Appel LJ, Braun, LT, Chatuvedi, S,Creager, MA, Crebras, A, Eckel, RH, Hart, Rg, Hincley, JA, Jauch, EC, Levine, SR, Meschia, JF, Moore, WS, Nixon, JV, Pearson, TA, et al. In: Guideline for the primary prevention of stroke: A Guideline for Healthcare Professionals from the American Heart Association/ American Stroke Association. Stroke Volume 42, Issue 2, year 2011, pp.517-584

306. Zierler RE, Beach KW, Bergelin RO, Lal BK, Moore WS, Roubin GS, Vocks JH, Brott TG For the CREST Investigators. Agreement between site-reported and ultrasound core laboratory results for duplex ultrasound core laboratory results for duplex ultrasound velocity measurements in the Carotid Revascularization Endarterectomy versus Stenting Trial. J Vasc Surg 2014;59: 2-7

307. Malas M, Glebova NO, Hughes SE, Voeks JH, Qazi U, Moore WS, Lal BK, Howard G, Llinas R, Brott TG. In: Effect of Patching on Reducing Restenosis in the Carotid Revascularization Endarterectomy Versus Stenting Trial. Stroke 2015;46:00-00

308. Howard G, Hopkins LN, Moore WS, Katzen BT, Chakhtoura E, Morrish WF, Ferguson RD, Hye RJ, Shawl FA, Harrigan MR, Voeks JH, Howard VJ, Lal BK, Meschia JF, Brott TG. Temporal Changes in Periprocedural Events in the Carotid Revascularization Endarterectomy Versus Stenting Trial. In: Stroke. 2015;46:00-00.DOI: 10.1161/STROKEA.115.008898.

309. Farley SM, Kashyap VS, Moore WS. Expanded Polytetrafluoroethylene and Dacron Grafts for Atherosclerotic Lower Extremity Occlusive Disease (Fifth edition) Elsevier Saunders, 2014

310. Moore WS, et al In: Carotid Angiographic Characteristics in the Crest Trial were Major Contributors To Periprocedural Stroke and Death Differences Between Carotid Artery Stenting and Carotid Endarterectomy. ( J Vasc Surg 2015;1-8.)

CHAPTERS

1. Moore WS. Emboli from the Carotid Bifurcation in the Pathogenesis of Cerebral Ischemic Attacks. In: Aspirin, Platelets and Stroke. Fields WS, Hass WK (Eds). Warren H. Green, St. Louis, MO 1971.

2. Moore WS. Amputation of the Lower Extremity in Arterial Occlusive Disease. In: Current Surgical Diagnosis and Treatment, Second Ed. Dunphy JE, Way LW (Eds). Lange Medical Publications, Los Altos, CA 1975.

3. Moore WS. Reoperations for Early and Late Occlusive Complications of Arterial Surgery. In: Vascular Surgery: Principles and Techniques. Haimovici H (Ed). Blakiston Publishing, McGraw- Hill Book Co., New York, NY, 1975.

4. Moore WS. Experimental Studies Relating to Sepsis in Prosthetic Vascular Grafting. Part III, Infections of Vascular Grafts. In: Infections of Prosthetic Heart Valves and Vascular Grafts: Prevention, Diagnosis, and Treatment. Duma RJ (Ed). University Park Press, Baltimore, MD, 1977.

5. Wylie EJ, Ehrenfeld WK, Moore WS. Arteries. In: Current Surgical Diagnosis & Treatment, Third Ed. Dunphy JE, Way LW (Eds). Lange Medical Publications, Los Altos, CA, 1977.

6–

22. Moore WS. Introduction

Anatomy of the Arterial Cerebral Circulation

Clinical Manifestations of Cerebrovascular Insufficiency Pathology in Extra-Cranial Cerebrovascular Disease

Pathogenetic Mechanisms for Cerebral Dysfunction in Vascular Disease Patient Evaluation

Indications for Operative Repair of Lesions of the Extra-Cranial Arterial Tree Operative Technique

Postoperative Management and Complications

Non-Operative Management of Cerebrovascular Occlusive Disease

Late Results of Medical and Surgical Therapy for Extra-Cranial Arterial Occlusive Disease

Extremity Amputation for Vascular Disease Overview

Patient Evaluation and Preparation for Amputation

Lower Extremity Amputation Levels: Indications, Technique, Prognosis Complications for Amputation

Immediate Postoperative Prosthesis

In: Vascular Surgery. Rutherford RB, Bernhard VM, Maddison FE, Moore WS, Perry MO, Sumner DS (Eds). W.B. Saunders Co., Philadelphia, PA, 1977.

23. Moore WS, Malone JM. Vascular Repair. In: Fundamentals of Wound Management in Surgery. Hunt TK, Dunphy JE (Eds). Appleton-Century-Crofts, New York, NY, 1979.

24. Moore WS. Infection of Vascular Grafts: Incidence, Bacteriology, and Pathogenesis. In: Complications in Vascular Surgery. Bernhard VM, Towne JB (Eds). Grune & Stratton, New York, NY, 1980.

25. Moore WS. The Isolated Popliteal Segment and Sequential Bypass. In: Femoro-Distal Bypass. Greenhalgh RM (Ed). Pitman Medical Publishers, England, 1981.

26. Moore WS, Malone JM. The Use of Prophylactic Antibiotics in Vascular Surgery. In: Surgical Infections. Condon RE, Gorback SL (Eds). Williams & Wilkins, Baltimore/London, 1981.

27. Moore WS, Malone JM. Mycotic Aneurysms. In: Aneurysms: Diagnosis and Treatment. Bergan JJ, Yao JST (Eds). Grune & Stratton, New York, NY, 1981.

28. Malone JM, Moore WS. Aortoiliac and Aortofemoral Grafts. Management of Early and Late Occlusive Complications. In: Vascular Emergencies. Haimovici H (Ed). Appleton-Century- Crofts, New York, NY, 1982.

29. Malone JM, Moore WS. Acute Bleeding Complications of Vascular Grafts. In: Vascular Emergencies. Haimovici H (Ed). Appleton-Century-Crofts, New York, NY, 1982.

30. Moore WS. Acute Cerebrovascular Disease. In: Vascular Emergencies. Ed. Haimovici H. Appleton-Century-Crofts, New York, NY 1982.

31. Moore WS. Amputation Level Determination Using Isotope Clearance Techniques. In: Noninvasive Diagnostic Techniques in Vascular Disease. Bernstein F (Ed). C.V. Mosby Co., St. Louis, MO 1982.

32. Moore WS. Management of Gangrene in Patients Without a Suitable Outflow Trace Below the Inguinal Ligament: Definition of True Unreconstructibility. In: Critical Problems in Vascular Surgery. Veith FJ (Ed). Appleton-Century-Crofts, New York, NY 1982.

33. Moore WS. Thrombosis of Aortofemoral, Axillofemoral, or Femorofemoral Grafts. In: Critical Problems in Vascular Surgery. Veith FJ (Ed). Appleton-Century-Crofts, New York, NY 1982.

34. Moore WS. Control of Vascular Graft Infectivity. In: Biologic and Synthetic Vascular Prosthesis. Stanley JC, Burkel WE, Lindenauer SM, Bartlett RH, Turcotte JG (Eds). Grune & Stratton, New York, NY 1982.

35. Malone JM, Moore WS. Cerebrovascular Disease in the Elderly. W.B. Saunders Co., New York, NY 1982.

36. Moore WS. Control of Vascular Graft Infectivity. In: Biologic and Synthetic Vascular Prostheses. Ed. Stanley JC. Grune & Stratton, Inc., New York, NY 1982.

37. Moore WS. Pathogenesis of Vascular Graft Sepsis. In: Extra Anatomic and Secondary Arterial Reconstruction Symposium. Greenhalgh RM (Ed). Pitman Publishers, London, 1982.

38. Moore WS, Bean BA. Periorbital Doppler Examination (Ophthalmosonometry) and Supraorbital Photoplethysmography. In: Practical Noninvasive Vascular Diagnosis. Kempczinski RF, Yao JST (Eds). Year Book Medical Publishers, Chicago, IL, 1982.

39. Moore WS. Surgical Significance and Management of the Ulcerated Carotid Plaque. In: Cerebrovascular Insufficiency. Eds. Bergan JJ, Yao JST. Grune and Stratton, New York, NY, 1982.

40. Moore WS. Immediate Postoperative Prosthesis Contributes to Optimum Amputation Management. In: Controversies in Surgery II. Delany PJ, Varco RL (Eds). W.B. Saunders Co., Philadelphia, PA, 1983.

41. Moore WS, Malone JM. Vascular Infection. In: Surgical Infectious Diseases. Simmons RL, Howard RJ (Eds). Appleton-Century-Crofts, New York, NY, 1982.

42–

43. Moore WS.

Mycotic Aneurysms Infected Aortic Grafts

In: Advances in Vascular Surgery. Najarian JS, Delaney JP (Eds). Year Book Medical Publishers, Inc., Chicago, IL, 1983.

44. Moore WS, Quiñones WJ. Extracranial Cerebrovascular Disease. In: Vascular Surgery. Moore WS (Ed). Grune and Stratton, Orlando, FL, 1983.

45. Moore WS. Reoperations for Early and Late Occlusive Complications of Arterial Surgery. In: Vascular Surgery: Principles and Techniques, Second Edition. Haimovici H (Ed). Appleton- Century-Crofts, Norwalk, CT, 1984.

46. Moore WS, Chvapil M. Development of an Infection-Resistant Vascular Graft. In: Recent Advances in Vascular Grafting—Proceedings of the International Symposium Held at the Catholic University in Nijmegen, The Netherlands. 26–28 April 1984. Skitnicki SH, Buskens FGM, Reinaerts HHM (Eds). System 4 Associates, Gerrards Cross, Buckinghamshire, England, 1985.

47. Malone JM, Moore WS. Preparation of the Patient and Determination of Amputation Level. In: The Ischemic Leg. Kempczinski RF (Ed). Year Book Medical Publishers, Inc., Chicago, IL, 1985.

48. Cole CW, Moore WS. The Natural History of Lesions of the Carotid Artery. In: Vascular Surgery: Issues in Current Practice. Greenhalgh RM, Jamieson CW, Nicolaides AN (Eds). Grune and Stratton, Ltd., London, England, 1986.

49–

50. Moore WS.

Extracranial Cerebrovascular Disease Infection in Prosthetic Vascular Grafts

In: Vascular Surgery: A Comprehensive Review, Second Edition. Moore WS (Ed). Grune & Stratton, Orlando, FL, 1986.

51. Cole CW, Moore WS. Emergency Amputation. In: Vascular Surgical Emergencies. Bergan JJ, Yao JST (Eds). Grune & Stratton, Inc., Orlando, FL, 1987.

52. Moore WS. Management of Ulcerative Lesions of the Carotid Artery: Symptomatic and Asymptomatic. In: Vascular Surgery: Principles and Practice. Wilson SE, Veith FJ, Hobson RW, Williams RA (Eds). McGraw Hill Book Company, New York, NY, 1987.

53–

60. Moore WS. Preface

The Role of the Vascular Laboratory in Diagnosis and Management of Patients with Cerebrovascular Disease

Indications for Angiography and Basis for Selecting the Type of Angiographic Study

Selective Shunting of the Carotid Artery: An Overview

The Use of Internal Carotid Artery Backpressure to Determine Shunt Requirement Technique of Carotid Endarterectomy

Asymptomatic Ulceration of the Carotid Artery: The Argument in Favor of Prophylactic Repair

Extrathoracic Repair of the Brachial-Cephalic Trunks

In: Surgery for Cerebrovascular Disease. Moore WS (Ed). Churchill Livingstone, New York, NY, 1987.

61–

62. Moore WS, Quiñones-Baldrich WJ.

Asymptomatic Carotid Stenosis: The Argument in Favor of Carotid Endarterectomy Immediate and Long-Term Results of Carotid Endarterectomy

In: Surgery for Cerebrovascular Disease. Moore WS (Ed). Churchill Livingstone, New York, NY, 1987.

63. Moore WS, Malone JM. Vascular Infection. In: Surgical Infectious Diseases, Second Edition. Howard RJ, Simmons RL (Eds). Appleton & Lange, Norwalk, CT, 1988.

64. Moore WS. Utilisation Sélective d’un Shunt Carotidien en Fonction de la Mesure de la Pression Résiduelle. In: Aspects Techniques de la Chirurgie Carotidienne. Kieffer E, Natali J (Eds). AERCV, Paris, France, 1987.

65. Ahn SS, Moore WS. Reoperative Arterial Surgery. In: Reoperative Surgery. Tompkins RK (Ed). JB Lippincott Company, Philadelphia, PA, 1988.

66. Moore WS. Asymptomatic Carotid Bruit. In: Common Problems in Vascular Surgery. Brewster DC (Ed). Year Book Medical Publishers, Inc., Chicago, IL, 1988.

67. Moore WS. Indications et Résultats de la Chirurgie des Lésions Carotidiennes Ulcérées. In: Indications et Résultats de la Chirurgie Carotidienne. Kieffer E, Bousser M-G (Eds). AERCV, Paris, France, 1988.

68–

69. Moore WS.

General Principles of Amputation Level Selection Below Knee Amputation

In: Lower Extremity Amputation. Moore WS, Malone JM (Eds). W.B. Saunders Company, Orlando FL, 1989.

70. Moore WS, Ahn SS. Amputation Level Selection by Isotope Clearance Techniques. In: Lower Extremity Amputation. Moore WS, Malone JM (Eds). W.B. Saunders Company, Orlando FL, 1989.

71. Moore WS. Extracranial Cerebral Vascular Disease. In: Current Surgical Therapy, Third Edition. Cameron JL (Ed). B.C. Decker, Inc., Philadelphia, PA, 1989.

72–

73. Moore WS.

Organization of the Multidisciplinary Team Atherectomy as an Alternative to Balloon Angioplasty

In: Endovascular Surgery. Moore WS, Ahn SS (Eds). W.B. Saunders Company, Philadelphia, PA, 1989.

74–

75. Moore WS, Ahn SS.

The Concept of Endovascular Surgery

Lesions Amenable to Mechanical Atherectomy: Clinical Strategies

In: Endovascular Surgery. Moore WS, Ahn SS (Eds). W.B. Saunders Company, Philadelphia, PA, 1989.

76–

77. Moore WS.

Fundamental Considerations in Cerebrovascular Disease

Indications and Surgical Technique for Repair of Extracranial Occlusive Lesions

In: Vascular Surgery, Third Edition. Rutherford RB (Ed). W.B. Saunders Company, Philadelphia, PA, 1989.

78–

79. Moore WS, Freischlag JA.

Infection in Prosthetic Vascular Grafts Anastomotic Aneurysms

In: Vascular Surgery, Third Edition. Rutherford RB (Ed). W.B. Saunders Company, Philadelphia, PA, 1989.

80. Moore WS, Quiñones-Baldrich WJ. Results of Medical and Surgical Therapy for Extracranial Arterial Occlusive Disease. In: Vascular Surgery, Third Edition. Rutherford RB (Ed). W.B. Saunders Company, Philadelphia, PA, 1989.

81–

83. Moore WS.

Fibrinolytic Drugs as an Adjunct to Arterial Thromboembolectomy

Current, Immediate, and Long-term Results of Surgery for Asymptomatic Lesions of the Carotid Artery

Carotid Endarterectomy to Prevent Stroke. I. Based on a Logical Evaluation of Available Information

In: Current Critical Problems in Vascular Surgery. Veith FJ (Ed). Quality Medical Publishing, Inc., St. Louis, MO, 1989.

84. Moore WS. Reoperative Carotid Artery Surgery. In: Techniques in Arterial Surgery. Bergan JJ, and Yao JST (Eds). W.B. Saunders Co., Philadelphia, PA, 1990.

85. Moore WS, Quiñones-Baldrich WJ. An Argument Against All-Autogenous Tissue for Vascular Bypasses Below the Inguinal Ligament. In: Advances in Surgery, Volume 24. Cameron JL, Balch DM, Langer B, Mannick JA, Sheldon GF, Shires GT, Tompkins RK, and Welch CE (Eds). Mosby Year Book, St. Louis, MO, 1991.

86. Moore WS. Technical Aspects of Carotid Endarterectomy for Atherosclerotic Disease. In: Current Therapy in Vascular Surgery, Second Edition. Ernst CB, Stanley JC (Eds). B.C. Decker Inc., Philadelphia, PA, 1991.

86a. Moore WS, Quiñones-Baldrich WJ. Extracranial Cerebrovascular Disease — The Carotid Artery. In: Vascular Surgery: A Comprehensive Review. Third Edition. Moore WS (Ed.) WB Saunders Co., 1991.

86b. Moore WS, Cole CW. Infection in Prosthetic Vascular Grafts. In: Vascular Surgery: A Comprehensive Review. Third Edition. Moore WS (Ed.) WB Saunders Co., 1991.

87. Moore WS. Below the Knee Amputation. In: Current Therapy in Vascular Surgery, Second Edition. Ernst CB, Stanley JC (Eds). B.C. Decker Inc., Philadelphia, PA, 1991.

88. Moore WS. Complications With Repair of the Supra-aortic Trunks and Vertebral Arteries. In: Complications in Vascular Surgery. Bernhard VM, Towne JB (Eds). Quality Medical Publishing, Inc., St. Louis, MO, 1991.

89. Ahn SS, Baker JD, Moore WS. Carotid Endarterectomy Based on Duplex Scanning Without Routine Arteriography. In: Perspectives in Vascular Surgery, Vol. 4, No. 1. Goldstone J (Ed). Quality Medical Publishing, Inc., St. Louis, MO 1991.

90. Ahn SS, Moore WS. Endovascular Surgery. In: Surgery Annual: 1992, Part 1. Nyhus LM (Ed). Appleton & Lange, San Mateo, CA 1991.

91. Colburn MD, Moore WS. Pharmacologic Control of Myointimal Hyperplasia. In: Technologies in Vascular Surgery. Yao JST, Pearce WH (Eds). W.B. Saunders Co., Philadelphia, PA 1991.

92. Moore WS. Carotid Endarterectomy for Asymptomatic Carotid Stenosis: Current Status in the United States. In: Chirurgie der hirnversorgenden Arterien. Hepp W, Palenker J (Eds). Quintessenz-Vrel.-GmbH, Munich, Germany, 1991.

93. Chervu A, Moore WS. Vascular Grafts and Sutures. In: Surgical Management of Vascular Disease. Bell PRF, Jamieson CW, Ruckley CV (Eds). W.B. Saunders Co., Ltd., London, England 1992.

94. Colburn MD, Moore WS. Strategies in the Management of Aorto-Femoral Graft Limb Occlusion. In: “Redo” Vascular Surgery — Renal, Aorto-Iliac and Infrainguinal Areas. (Serono

Symposia Publications from Raven Press; v 87). Spartera C, Courbier R, Fiorani P, Imparato AM (Eds). Raven Press, New York 1992.

95–

97. Moore WS.

Atherectomy as an Alternative to Balloon Angioplasty Organization of the Multidisciplinary Team

Current Therapy of Intimal Hyperplasia

In: Endovascular Surgery, Second Edition. Ahn SS, Moore WS (Eds). W.B. Saunders Company, Philadelphia, PA, 1992.

98–

99. Moore WS, Ahn SS.

The Concept of Endovascular Surgery

Lesions Amenable to Mechanical Atherectomy: Clinical Strategies

In: Endovascular Surgery, Second Edition. Ahn SS, Moore WS (Eds). W.B. Saunders Company, Philadelphia, PA, 1992.

100. Colburn MD, Moore WS. Contrôle pharmacologique de l’hyperplasie intimale anastomotique.

In: Le Remplacement Artèriel: Principes et Applications. Kieffer E (Ed). AERCV, Paris, 1992.

101. Moore WS. Choice of Graft Material for Femoropopliteal Bypass: The Case for Preferential Use of PTFE. In: Current Critical Problems in Vascular Surgery, Vol. 4. Veith F (Ed). Quality Medical Publishing, Inc., St. Louis, MO, 1992.

102–

104. Colburn MD, Moore WS.

Relative Value of Duplex Scannigraphy in the Preoperative Evaluation of Symptomatic Carotid Disease

The Value of Carotid Endarterectomy in Symptomatic Patients The Risk of Carotid Endarterectomy in Asymptomatic Patients

In: Cerebral Revascularization. Bernstein EF, Callow AD, Nicolaides AN, Shifrin EG (Eds). Med-Orion Publishing Co., London, England, 1993.

105–

106. Moore WS.

Recurrent Carotid Stenosis

The Asymptomatic Carotid Artery Stenosis Study (ACAS)

In: Cerebral Revascularization. Bernstein EF, Callow AD, Nicolaides AN, Shifrin EG (Eds). Med-Orion Publishing Co., London, England, 1993.

107. Moore WS. Extracranial Cerebrovascular Disease—The Carotid Artery. In: Vascular Surgery: A Comprehensive Review, Fourth Edition. Moore WS (Ed). W.B. Saunders Company, Philadelphia, PA, 1993.

108. Colburn MD, Moore WS. Myointimal Hyperplasia. In: Vascular Surgery: A Comprehensive Review, Fourth Edition. Moore WS (Ed). W.B. Saunders Company, Philadelphia, PA, 1993.

109. Moore WS, Deaton DH. Infection in Prosthetic Vascular Grafts. In: Vascular Surgery: A Comprehensive Review, Fourth Edition. Moore WS (Ed). W.B. Saunders Company, Philadelphia, PA, 1993.

110. Moore WS. Endovascular Grafting Technique: A Feasibility Study. In: Aneurysms: New Findings and Treatments. Yao JST, Pearce WH (Eds). Appleton and Lange, Norwalk, CT, 1993.

111. Colburn MD, Moore WS. Drug Prophylaxis for the Prevention of Intimal Hyperplasia. In: Current Critical Problems in Vascular Surgery, vol. 5. Veith FJ (Ed). Quality Medical Publishing, Inc., St. Louis, MO, 1993.

112. Gelabert HA, Moore WS. Management of Ulcerative Lesions of the Carotid Artery: Symptomatic and Asymptomatic. In: Vascular Surgery: Principles and Practice, Second Ed. Veith FJ, Hobson RW II, Williams RA, Wilson SE (Eds). McGraw-Hill, Inc., New York, NY, 1994.

113. Colburn MD, Moore WS. Carotid Endarterectomy. In: Rob & Smith’s Operative Surgery: Vascular Surgery, Fifth Edition. Jamieson CW, Yao JST (Eds). Chapman & Hall, London, 1994.

114. Moore WS. Transfemoral Endovascular Repair of Abdominal Aortic Aneurysm Using the Endovascular Graft System Device. In: Vascular and Endovascular Surgical Techniques: An Atlas, Third Edition. Greenhalgh RM (Ed). WB Saunders Co, London, 1994.

115. Gelabert HA, Moore WS. Occlusive Cerebrovascular Disease: Medical and Surgical Considerations. In: Anesthesia and Neurosurgery, Third Edition. Cottrell JE, Smith DS (Eds). Mosby-Year Book, Inc., St. Louis, MO, 1994.

116. Gelabert HA, Moore WS. The Role of In Situ Graft Replacement in Abdominal Aortic Infections. In: Management of Infected Arterial Grafts. Calligaro KD, Veith FJ (Eds). Quality Medical Publishing, Inc., St. Louis, MO 1994.

117. Colburn MD, Moore WS. Risk Benefit Aspects of Surgery for Asymptomatic Carotid Stenosis. In: Risk Benefit Aspects of Vascular Surgery. Swedenborg J, Blohme L (Eds). Karolinska Institute, Stockholm, Sweden, 1994.

118. Colburn MD, Moore WS. Surgery or Endovascular Surgery for Chronic Lower Extremity Ischemia: What Selection Criteria Should We Use? In: Risk Benefit Aspects of Vascular Surgery. Swedenborg J, Blohme L (Eds). Karolinska Institute, Stockholm, Sweden, 1994.

119. Moore WS, Gelabert HA, Colburn MD. Development of an Antibiotic-Protected Vascular Prosthesis Using a Collagen-Bonded Release System. In: Vascular Graft Infections. Bunt TJ (Ed). Futura Publishing Co., Inc., Armonk, NY, 1994.

120. Law MM, Moore WS. Pharmacological Inhibition of Intimal Hyperplasia in Intact Organisms.

In: Intimal Hyperplasia. Dobrin PB (Ed). RG Landes Co., Austin, TX, 1994.

121. Gelabert HA, Moore WS. Carotid Restenosis. In: Advances in Vascular Surgery, vol 2. Whittemore AD, Bandyk DF, Cronenwett JL, Hertzer NR, White RA (Eds). Mosby-Year Book, Inc., St. Louis, MO, 1994.

122. Colburn MD, Moore WS. Risk-Benefit Aspects of Surgery for Asymptomatic Carotid Artery Stenosis. In: Perspectives in Vascular Surgery. Goldstone J (Ed). Quality Medical Publishing, Inc. 1994.

123–

125. Moore WS.

Anastomotic Aneurysms.

Fundamental Considerations in Cerebrovascular Disease.

Indications and Surgical Technique for Repair of Extracranial Occlusive Lesions

In: Vascular Surgery, Fourth Edition. Rutherford RB (Ed.). WB Saunders Co., Philadelphia, PA, 1995.

126. Quiñones-Baldrich WJ, Moore WS. Results of Medical and Surgical Therapy for Extracranial Arterial Occlusive Disease. In: Vascular Surgery, Fourth Edition. Rutherford RB (Ed.). WB Saunders Co., Philadelphia, PA, 1995.

127. See item 86a.

128. See item 86b.

129. Gelabert HA, Moore WS. Vascular Infection. In: Surgical Infectious Diseases, Third Edition. Howard RJ, Simmons RL (Eds). Appleton and Lange, Norwalk, CT, 1995.

130. Colburn MD, Moore WS. Cerebrovascular Disease. In: General Surgery. Ritchie WP Jr., Steele G Jr., Dean RH (Eds). JB Lippincott Co., Philadelphia, PA 1995.

131. Deaton DH, Moore WS. Nonatherosclerotic Disease of the Cerebral Vasculature. In: Current Diagnosis & Treatment in Vascular Surgery. Dean RH, Yao JST, Brewster DC (Eds). Appleton

& Lange, Norwalk, CT, 1995.

132. Deaton DH, Moore WS. Blood Pressure Instability Following Carotid Endarterectomy. In: Current Therapy in Vascular Surgery, Third Edition. Ernst CB, Stanley JC (Eds). Mosby-Year Book, Inc., St. Louis, MO, 1995.

133. Moore WS. Carotid Endarterectomy. In: Current Surgical Therapy, Fifth Edition. Cameron JL (Ed). Mosby-Year Book Inc., London, 1995.

134. Colburn MD, Moore WS. Surgery or Endovascular Surgery for Chronic Lower Extremity Ischemia: What Selection Criteria Should We Use? In: Perspectives in Vascular Surgery, vol 8. Goldstone J (Ed). Quality Medical Publishing, Inc., St Louis, MO, 1995.

135. Hajjar GE, Moore WS. Chirurgia carotidea d’urgenza. In: Chirurgia Vascolare. Belardi P (Ed). Edizioni Minerva Medica, Torino, Italy, 1995.

136. Colburn MD, Moore WS. Pharmacologic Management of Intimal Hyperplasia. In: Arterial Surgery: Management of Challenging Problems. Yao JST, Pearce WH (Eds). Appleton & Lange, Stamford, CT, 1996.

137. Moore WS, Bock RW, Haimovici H. Reoperation for Early and Late Occlusive Complications of Arterial Surgery. In: Haimovici’s Vascular Surgery, Fourth Edition. Haimovici H, et al (Eds). Blackwell Science, Inc., Cambridge, MA, 1996.

138. Colburn MD, Moore WS. Relative Value of Duplex Scanning and Angiography in the Preoperative Evaluation of Symptomatic Carotid Disease. In: Cerebrovascular Ischaemia: Investigation & Management. Caplan LR, Shifrin EG, Nicolaides AN, Moore WS (Eds). Med- Orion Publishing Company, London, England, 1996.

139. Moore WS. Asymptomatic Carotid Stenosis: Lessons Learned from the Randomized Trials. In: Cerebrovascular Ischaemia: Investigation & Management. Caplan LR, Shifrin EG, Nicolaides AN, Moore WS (Eds). Med-Orion Publishing Company, London, England, 1996.

140. Moore WS. Current Indications for Carotid Endarterectomy. In: Cerebrovascular Ischaemia: Investigation & Management. Caplan LR, Shifrin EG, Nicolaides AN, Moore WS (Eds). Med- Orion Publishing Company, London, England, 1996.

141–

149. Moore WS.

Preface to Second Edition.

Role of the vascular laboratory in diagnosis and management of patients with cerebrovascular disease.

Indications for angiography and basis for selecting type of angiographic study The natural history of asymptomatic carotid ulceration

The American Heart Association Consensus Committee statement concerning indications for carotid endarterectomy in asymptomatic patients

Selective shunting of the carotid artery: An overview

The use of internal carotid artery back pressure to determine shunt requirement Technique of carotid endarterectomy

Extrathoracic repair of the brachiocephalic trunks

In: Surgery for Cerebrovascular Disease. Moore WS (Ed). WB Saunders Company, Philadelphia, PA, 1996.

150. Moore WS. Problems encountered with EVT devices (tube and bifurcated) for treatment of abdominal aortic aneurysms. In: Current Critical Problems in Vascular Surgery, Volume 7. Veith FJ (Ed). Quality Medical Publishing, Inc., St Louis, MO, 1996.

151. Moore WS, Colburn MD. Carotid body tumors. In: Mastery of Surgery, third edition. Nyhus LM, Baker RJ, Fischer JE (Eds). Little, Brown and Company, Boston, MA, 1997.

152. Moore WS. Endovascular repair of abdominal aortic aneurysm—An update on the multicenter endovascular graft system trial. In: Progress in Vascular Surgery. Yao JST, Pearce WH (Eds). Appleton & Lange, Stamford, CT, 1997.

153. Moore WS. Physiopathologie et Classification des Infections Artérielles. In: Infections Artérielles. Kieffer E, Goeau-Brissonniere O, Pechere JC (Eds). Editions AERCV, Paris, France, 1997.

154-

156. Moore WS.

Preface to the Fifth Edition

Extracranial Cerebrovascular Disease: The Carotid Artery Infection in Prosthetic Vascular Grafts

In: Vascular Surgery: A Comprehensive Review, Fifth Edition. Moore WS (Ed). W.B. Saunders Company, Philadelphia, PA, 1998.

157. Moore WS, Marin ML. Endovascular Grafting. In: Vascular Surgery: A Comprehensive Review, Fifth Edition. Moore WS (Ed). W.B. Saunders Company, Philadelphia, PA, 1998.

158. Colburn MD, Moore WS. Myointimal Hyperplasia. In: Vascular Surgery: A Comprehensive Review, Fifth Edition. Moore WS (Ed). W.B. Saunders Company, Philadelphia, PA, 1998.

159. Moore WS. The EVT Aortic Tube Graft and Bifurcation Graft. In: Techniques in Vascular and Endovascular Surgery. Yao JST, Pearce WH (Eds). Appleton & Lange, Stamford, CT, 1998.

160. Colburn MD, Moore WS. The Role of Duplex, MRA, and Angiography in the Evaluation of Carotid Artery Disease. In: Vascular Intervention: A Clinical Approach. Perler BA, Becker GJ (Eds). Thieme Medical Publishers, Inc., New York, NY, 1998.

161. Moore WS. Carotid Endarterectomy Without Angiography: Preoperative Assessment and Selection of Patients. In: New Trends and Developments in Carotid Artery Disease. Branchereau A, Jacobs M (Eds). Futura Publishing Co., Inc., Armonk, NY, 1998.

162. Moore WS. Endovascular Graft Treatment for Aortic Aneurysms. In: Current Surgical Therapy, Sixth Edition. Cameron JL (Ed). Mosby, Inc., St. Louis, MO, 1998.

163. Moore WS. Internal Carotid Artery Back Pressure to Determine Shunt Requirement. In: Perioperative Monitoring in Carotid Surgery: Methods, Limits and Results; Long-Term Results in Carotid Surgery. Horsch S, Ktenidis K (Eds). Steinkopff, Darmstadt; Springer, Budapest, 1998.

164. Moore WS. Transfemoral Endovascular Repair of Abdominal Aortic Aneurysms: Feasibility Study of the EGS System. In: Endovascular Grafting Techniques. Parodi JC, Veith FJ, Marin ML (Eds). Williams & Wilkins, Baltimore, MD, 1999.

165. Moore WS. Endovascular Repair of Abdominal Aortic Aneurysm. In: Crucial controversies in Surgery, Vol. 3. Schein M, Wise L (Eds). Lippincott Williams & Wilkins, Philadelphia, PA, 1999.

166. Moore WS. Fundamental Considerations in Cerebrovascular Disease. In: Vascular Surgery, Fifth Edition. Rutherford RB (Ed.). WB Saunders Co., Philadelphia, PA, 1999.

167. Moore WS, Quiñones-Baldrich WJ, Krupski WC. Indications, Surgical Technique, and Results for Repair of Extracranial Occlusive Lesions. In: Vascular Surgery, Fifth Edition. Rutherford RB (Ed.). WB Saunders Co., Philadelphia, PA, 1999.

168. Kashyap V, Moore WS. Emergency Carotid Revascularization for Acute Ischemic Stroke. In:

Management of Ischemic Stroke. Cohen SN (Ed.). McGraw Hill, St. Louis, MO, 2000.

169. Moore WS. Stroke Associated With Carotid Endarterectomy. In: Management of Ischemic Stroke. Cohen SN (Ed.). McGraw Hill, St. Louis, MO, 2000.

170. Moore W. Identification and Investigation of Patients with Asymptomatic Carotid Stenosis. In: 13th Congress of the European Chapter of the International Union of Angiology. Rastounis EA (Ed.). Monduzzi Editore, Bologna, Italy, 1999.

171. Moore, WS. The Randomized Trials for Symptomatic Carotid Disease: How Should They Influence my Daily Practice? In: Carotid Artery Surgery-A Problem Based Approach. In: Naylor AR, Mackey WC (Eds). WB Saunders Co., Philadelphia, PA, 2000.

172. Moore WS. Extracranial Cerebrovascular Disease. In: Surgical Decision Making (Fourth Edition). Norton LW, Van Stiegman G, Eiseman B (Eds). WB Saunders Co., Philadelphia, PA, 2000.

173. Moore WS. Abdominal Aortic Aneurysm: Transabdominal or Endovascular Repair? In: Advances in Surgery, vol 34. Cameron JL (Ed.). Mosby, Inc., St. Louis, MO, 2000.

174. Kashyap VS, Moore W. Emergency Carotid Revascularization for Acute Ischemic Stroke. In: Management of Ischemic Stroke. Cohen SN (Ed.). McGraw-Hill, New York, NY, 2000

175. Moore W. Stroke Associated with Carotid Endarterectomy. In: Management of Ischemic Stroke. Cohen SN (Ed.). McGraw-Hill, New York, NY, 2000

176. Moore W. Surgical Management of Asymptomatic Carotid Artery Atherosclerosis. In: Current Therapy in Vascular Surgery, Fourth Edition. Ernst CB, Stanley JC (Eds). Mosby, St. Louis, MO, 2001.

177. Gelabert HA, Moore W. Occlusive Cerebrovascular Disease: Medical and Surgical Considerations. In: Anesthesia and Neurosurgery. Cottrell JE, Smith DS (Eds). Mosby, St. Louis, MO, 2001.

178. Moore WS. The Concept of Endovascular Surgery. In: Endovascular Surgery, Third Edition.

Moore WS, Ahn SS (Eds). WB Saunders Company, Philadelphia, PA, 2001.

179. Moore WS, Beebe HG, Chuter TAM, Fairman RM, Matsumura JS. Abdominal Aortic Aneurysm. In: Endovascular Surgery, Third Edition. Moore WS, Ahn SS (Eds). WB Saunders Company, Philadelphia, PA, 2001.

180. Moore WS. Carotid Body Tumors. In: Mastery of Surgery, Fourth Edition, Volume I. Baker RJ, Fischer JE (Eds). Lippincott Williams & Wilkins, Philadelphia, PA, 2001.

181. Kafie FE, Moore WS. Management of Cerebrovascular Disease. In: The Practice of General Surgery. Bland KI (Ed). WB Saunders Company, Philadelphia, PA, 2001.

182. Moore WS. Carotid Arterial Procedures. In: American College of Surgeons ACS Surgery Priinciples & Practice. Wilmore DW, Cheung LY, Harken AH, Holcroft JW, Meakins JL, Soper NJ (Eds). WebMD Corp., New York, NY 2001.

183-

185. Moore WS.

Preface to the Fifth Edition

Extracranial Cerebrovascular Disease: The Carotid Artery Infection in Prosthetic Vascular Grafts

In: Vascular Surgery: A Comprehensive Review, Sixth Edition. Moore WS (Ed). W.B. Saunders Company, Philadelphia, PA, 2001.

186. Moore WS, Marin ML. Endovascular Grafting. In: Vascular Surgery: A Comprehensive Review, Sixth Edition. Moore WS (Ed). W.B. Saunders Company, Philadelphia, PA, 2001.

187. Colburn MD, Moore WS. Myointimal Hyperplasia. In: Vascular Surgery: A Comprehensive Review, Sixth Edition. Moore WS (Ed). W.B. Saunders Company, Philadelphia, PA, 2001.

188. Moore WS. Endovascular repair of abdominal aortic aneurysm: the aorto-biiliac approach. In: Minimal Access Therapy for Vascular Disease. Leahy AL, Bell PRF, Katzen BT (Eds). Martin Dunitz Ltd., London, England, 2002.

189. Moore WS. Management of Patients with Carotid Bifurcation Disease. In: Vascular Surgery: Cases, Questions and Commentaries. Geroulakos G, van Urk H, Hobson RW II, and Calligaro K (eds). Springer-Verlag London Limited, London, England, 2003.

190. Moore WS. Benefits of carotid endarterectomy for symptomatic and asymptomatic patients as proven in prospective randomized trials. In: Angioplasty and Stenting of the Carotid and Supra- Aortic Trunks. Henry M, Ohki T, Polydorou A, Strigaris K, Kiskinis (eds). Martin Dunitz, London, England, 2004.

191. Moore WS. Carotid Arterial Procedures. In:ACS Surgery – Principles and Practice 2004Wilmore DW, et al, (eds). American College of Surgeons. Web MD, New York, NY, 2004.

192. Moore WS. Recurrent Carotid Stenosis. In: Current Surgical Therapy, Eighth Edition. Cameron JL (ed). Elsevier Mosby, Philadelphia, PA 2004.

193. Moore WS. Extracranial Cerebrovascular Disease. In: Surgical Decision Making, Fifth Edition. McIntyre RC Jr., Stiegmann GV, Eiseman B (eds). Elsevier Saunders, Philadelphia, PA 2004.

194. Moore WS. Should NASCET and ACAS be Repeated? In: Trends in Vascular Surgery. Pearce WH, Matsumura JS, Yao JST (eds). Greenwood Academic, Evanston, IL 2005.

195. Moore WS. Carotid body tumors. In: Mastery of Surgery, Fourth Edition. Baker RJ, Fisher JE (eds). Lippincott, Williams and Wilkins, Philadelphia, PA 2001.

196. Moore WS. Management of Patients with Carotid Bifurcation Disease. In: Vascular Surgery – Cases, Questions and Commentaries, Second Edition. Geroulakos G, van Urk H, Hobson RW II (eds). Springer-Verlag London Limited, London, England 2006.

197. Moore WS. Carotid Body Tumors. In: Mastery of Surgery, Fifth Edition, Volume II. Fischer JE (ed), Bland KI (assoc ed), Callery MP, et al (section eds). Lippincott Willliams & Wilkins, Philadelphia, PA 2007.

198. Biggs KL, Moore WS. Current Trends in Managing Carotid Artery Disease. In: Vascular Surgery: New Concepts and Practice for the General Surgeon. Starnes BW, Martin RF (eds). Elsevier Saunders, Philadelphia, PA 2007.

199. Moore WS. Carotid Body Tumors. In: Mastery of Surgery, Sixth Edition, Volume II. Fischer JE (ed), Jones DB, Pomposelli FB, Upchurch GR (assoc. eds). Lippincott Williams & Wilkins, Philadelphia, PA 2012.

200. Moore, WS. Carotid Endarterectomy. In: Vascular Medicine: A Companion to Braunwald’s Heart Disease (Second eds) Elsevier Saunders, 2013

201. Farley SM, Moore WS. Role of Shunting During Carotid Endarterectomy (Fifth Edition) Elsevier

Saunders, 2014

202. Farley SM, Kashyap VS, Moore WS. Expanded Polytetrafluoroethylene and Dacron Grafts for Atherosclerotic Lower Extremity Occlusive Disease (Fifth edition) Elsevier Saunders, 2014

203. Moore WS, et al In: Carotid Angiographic Characteristics in the Crest Trial were Major Contributors To Periprocedural Stroke and Death Differences Between Carotid Artery Stenting and Carotid Endarterectomy. ( J Vasc Surg 2015;1-8.)

202. Moore WS. Issues to be Addressed and Hopefully Resolved in the Carotid Revascularization Endarterectomy Versus Stenting Trial 2. (Angiology 2016, Vol 67(5) 408-410)

ABSTRACTS

1. Rosson CT, Moore WS, Ketchum SA, et al. Hemodynamic Effect of Progressive Arterial Stenosis of Obligatory Iliac Artery Blood. Clin Res 1968; 16: 111.

2. Moore WS, Hall AD. Below-Knee Amputation for Vascular Insufficiency with Immediate Fitting of Prosthesis. J Cardiovasc Surg 1970; 11(Supp to No. 3): 261–262.

3. Moore WS, Hall AD. Ulcerated Atheroma of the Carotid Bifurcation: A Major Cause of Transient Cerebral Ischemia. J Cardiovasc Surg 1970; 11(Supp to No. 3): 235.

4. Moore WS. Reflections on the Mechanism and Significance of Arterial Hypertension Following Cerebral Arterial Occlusion. Annotation, Am Heart J 1972; 38: 286–287.

5. Moore WS, Bean B, Burton R, Goldstone J. The Use of Ophthalmosonometry in the Diagnosis of Carotid Stenosis. Stroke 1976; 7: 2.

6. Malone JM, Moore WS, Goldstone J. The Natural History of Aorto-bilateral Bypass Grafts for Lower Extremity Ischemia. J Cardiovasc Surg 1976; 17: 83.

7. Roon AJ, Moore WS, Goldstone J. Below-Knee Amputation: A Modern Approach. Orth Digest, 1978; Mar: 21–22.

8. Goldstone J, Malone JM, Moore WS. Inflammatory Aneurysms of the Abdominal Aorta. Surg Gyn & Obst 1979; 148: 315.

9. Hunter GC, Sieffert G, Malone JM, Moore WS. The Accuracy of Carotid Artery Back Pressure as an Index for Shunt Requirement: A Reappraisal. J Cardiovasc Surg 1981; 22: 418.

10. Raviola C, Wheeler N, Nichter L, Baker J, Moore WS. Stepwise Logistic Regression—A Model for Predicting Success of Femoral-Popliteal Bypass Grafts. Langenbecks Arch Surg. O Boeckl, E Hell, O Staindl (Eds). p. 174, Abstract #43.

11. Moore WS. Efficacy of Carotid Endarterectomy in Randomized Trials. West J Med 155: 407.

12. McCrory DC, Goldstein LB, Samsa GP, Oddone EZ, Landsman P, Moore WG, Matchar DB. Predicting complications of carotid endarterectomy. Medical Decision Making 1993; 13(4): 393.

13. Flamm SD, Gomes AS, Vescera CL, Moore WS. MRI/MRA vs. CT and angiography in the evaluation of abdominal aortic aneurysms. Circulation Suppl 1993; 88(4, part II): I–100.

13a. Petrik P, Gelabert H, Moore W, Quiñones-Baldrich W, Law M. Cigarette smoking accelerates carotid artery restenosis in a dose-dependent manner. Stroke 1995; 1: 171.

13b. Ahn S, Braithwaite B, Petrik P, Concepcion B, Moore W, Clem M. Laparoscopic aortofemoral bypass. British J Surg 1995; 82: 560.

13c. Petrik P, Gelabert H, Moore W, Quiñones-Baldrich W, Law M. Cigarette smoking accelerates carotid intimal hyperplasia in a dose-dependent manner. International Angiology 1995; 14; 1(Suppl 1): 180.

14. Braithwaite BD, Petrik PV, Jones L, Quiñones-Baldrich WJ, Moore WS, Earnshaw JJ (introduced by Frandon JR). Aspirin influences local and distant effects of ischaemia-reperfusion syndrome. British J Surg 1995; 82: 696.

14a. Ahn S, Clem M, Braithwaite B, Concepcion B, Petrik P, Moore W. Laparoscopic aortofemoral bypass: Preliminary animal results. Minimally Invasive Therapy 1995; 4: 9.

14b. Petrik P, Braithwaite B, Gelabert H, More W, Quiñones-Baldrich W. Pentoxifylline improves skeletal muscle recovery after acute ischemic and reperfusion injury. Abstracts Outline. Joint Annual Meeting of the Society for Vascular Surgery and the International Society for Cardiovascular Surgery (North American Chapter), New Orleans, LA, June 1995: 45.

14c. Petrik P, Gelabert H, Moore W, Quiñones-Baldrich W. Does prefixation vascular tone affect calculation of intimal hyperplasia in the injured rat carotid artery? Abstracts Outline. Joint Annual Meeting of the Society for Vascular Surgery and the International Society for Cardiovascular Surgery (North American Chapter), New Orleans, LA, June 1995: 46.

14d. Petrik P, Gelabert H, Moore W, Quiñones-Baldrich W, Law M. Cigarette smoking accelerates carotid artery intimal hyperplasia in a dose-dependent manner. Eur J Neurol 1995; 2: 9.

15. Moore WS. Randomized Prospective Studies on Carotid Stenosis: Views from the Vascular Surgeon (Surgical Viewpoint). The Proceedings of the Straub Foundation 1996; 60: 23–24.

16. Moore WS. Carotid Endarterectomy: Indications (Asymptomatic vs. Symptomatic). The Proceedings of the Straub Foundation 1996; 60: 35.

17. Moore WS. Intervention in Acute Carotid Artery Occlusion. The Proceedings of the Straub Foundation 1996; 60: 47–48.

18. Moore WS. Carotid Surgery for Prevention of Stroke. The Proceedings of the Straub Foundation 1996; 60: 82-83.

19. See 13a.

20. See 13b.

21. See 13c.

22. See 14a.

23. See 14b.

24. See 14c.

25. See 14d.

26. Reil T, Shekherdemian S, Golcher P, Moore W. The Safety of Carotid Endarterectomy in Patients with Preoperative Renal Dysfunction. Southern California Vascular Surgery Society, 19th Annual Meeting. 2001; 34.

27. Kansal N, Huang C, Angle N, Baker JD, Farooq MM, Gelabert HA, Ahn SS, Quiñones W, Moore WS, Freischlag JA. Tibial Bypass in a Tertiary Medical Center: Redo is the Reality. Western Vascular Society 16th Annual Meeting. 2001; 52-53.

28. Moore WS, Beseth B. XXII.6 Open Posterior Approach to Popliteal Aneurysm Repair Prevents Sac Enlargement from Endoleak and Is Better than Endograft Repair and Ligation and Bypass. Vascular. 2005; 13(Supp 1): S100-S101.

29. Paraskevas KI, Veith FJ, Riles TS, Moore WS. Is Carotid Artery Stenting a Fair Alternative to Carotid Endarterectomy for Symptomatic Carotid Artery Stenosis? Eur J Vas Endovasc Surg (2011) 41, 717-719

30. Paraskevas KI, Moore WS, Veith FJ. Carotid Artery Stenting: Still Not as Cost-Effective as Carotid Endarterectomy, but the Contest Continues (2014) 21:303-305

31. Moore WS. Issue to Be Addressed and Hopefully resolved in the Carotid Revascularization Endarterectomy Versus Stenting Trial 2. Angiology 2015 Oct 11, 2015

32. Brott TG, Howard G, Roubin GS, Meschia JF, Mackey A, Brooks W, Moore WS, et al.

Long-Term Results of Stenting Versus Endarterectomy for Carotid Artery Stenosis. The New England Journal of Medicine (2016) Feb. 18, 2016

SCIENTIFIC EXHIBITS

1. Amputation with Immediate Ambulation. American College of Surgeons

American Medical Association National Medical Association Association of Military Surgeons

2. To Shunt or Not to Shunt—Use of Carotid Artery Back Pressure. American College of Surgeons

American Heart Association

MEDICAL FILMS

1. Axillary Femoral Bypass for Lower Extremity Ischemia.

2. Below-Knee Amputation with Immediate Postoperative Prosthesis.

3. Syme’s Amputation with Immediate Ambulation.

4. The Trans-Cervical Approach for Common Carotid Endarterectomy. (Included in Motion Picture Library of the American College of Surgeons). 1989.

5. Transfemoral Endovascular Graft Repair of Abdominal Aortic Aneurysm. 1993.

6. Transfemoral Endovascular Repair of Abdominal Aortic Aneurysm with a Bifurcated Graft. 1997.

EDITORIALS

1. The Asymptomatic Carotid Bruit—A Meaningless Term. Vascular Diagnosis & Therapy, Vol. 3, No. 5, Aug/Sept 1982.

ARTICLES PUBLISHED CONCERNING WORK

1. Immediate Fitting of Prosthesis After Amputation. Contemporary Surgery, 1972; 7: 47–56.

2. Carotid Pressure Linked to Use of Internal Shunt. Surgical Advance, 1973; 4: News Briefs, p.1.

SCIENTIFIC PRESENTATIONS

(2006–Present)

Invited Guest (1) “Current Status of Carotid Angioplasty and Stenting for Carotid Occlusive Speaker: Disease.” (2) “Methods of Repair for Popliteal Artery Aneurysm.”

South Florida Vascular Surgical Society, Marco Island, FL, February 3-5, 2006.

Course Director

& Moderator: 24th Annual UCLA Symposium: A Comprehensive Review and Update of What’s New in Vascular and Endovascular Surgery, Beverly Hills, CA, October 1-5, 2006.

Talk: “Cerebrovascular Disease I: Surgery of the Carotid Artery.” 24th Annual UCLA Symposium: A Comprehensive Review and Update of What’s New in Vascular and Endovascular Surgery, Beverly Hills, CA, October 1-5, 2006.

Invited Guest (1) “Carotid Endarterectomy Versus Angioplasty: Current Status of the Lecturer: Controversy.” (2) “The Posterior Approach for Direct Repair of Popliteal

Aneurysm.” 24th Annual Meeting, Pacific Northwest Vascular Society, Spokane, WA, November 9, 2006.

Guest Speaker: Program Moderator and talk: “Tips and Tricks in the Management of Carotid Body Tumors.” Veith Symposium, New York City, NY, November 15-19, 2006.

Invited Guest Harris B. Schumacker, Jr., Distinguished Lecture: Carotid endarterectomy versus Speaker: carotid angioplasty and stenting: Current status of the controversy.” 35th Annual

Meeting, Society for Military Vascular Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, November 30-December 2, 2006.

Invited Speaker: “Carotid endarterectomy versus angioplasty – What is the current status?” Cleveland Vascular Society meeting, Cleveland, OH, May 2, 2007.

Invited Guest: “The posterior approach for popliteal artery aneurysm repair.” Cleveland Clinic, Cleveland, OH, May 3, 2007.

Course Director

& Moderator: 25th Annual UCLA Symposium: A Comprehensive Review and Update of What’s New in Vascular and Endovascular Surgery, Beverly Hills, CA, September 30 – October 4, 2007.

Invited Presentation “Carotid endarterectomy: Standard Approach.” Cine-Clinics, Clinical Congress and Video: of the American College of Surgeons, New Orleans, LA, October 10, 2007.

Session Moderator

and Talk: “Consequences of Early and Late Open Conversion Following EVAR: How to Make it Less Morbid.” Veith Symposium, New York, NY, November 14-18, 2007.

Invited Speaker: “Carotid Stenting versus Endarterectomy: Current Status.” 26th Annual Meeting: Southern California Vascular Surgery Society. Westlake Village, CA, May 2-4, 2008.

Course Director

& Moderator: 26th Annual UCLA Symposium: A Comprehensive Review and Update of What’s New in Vascular and Endovascular Surgery, Beverly Hills, CA, September 2-6, 2008.

Invited Speaker: “Registry Data are not Adequate to Support Widespread Adoption of Carotid Angioplasty/Stent.” Veith Symposium, New York City, NY, November 19-22, 2008.

Invited Speaker: “Update on carotid artery stenting/open endarterectomy.” Houston Aortic Symposium: Frontiers in Cardiovascular Diseases, Houston, TX, March 26-28, 2009.

Invited Speaker: Earl Gordon Memorial Lecture: “Carotid Endarterectomy Versus Carotid Angioplasty, Current Status of the Controversy.” Wadsworth Medical and Surgical Alumni meeting, April 4, 2009.

Invited Speaker: “Status of the Controversy of Carotid Endarterectomy versus Carotid Angioplasty”

World Federation of Vascular Societies Symposium, Oslo, Norway, September 3, 2009.

Course Director

& Moderator: 27th Annual UCLA Symposium: A Comprehensive Review and Update of What’s New in Vascular and Endovascular Surgery, Beverly Hills, CA, September 14-17, 2009

Invited Speaker: “Current Status of the CREST Trial.” VEITH, New York, New York, Nov 18-22, 2009

Invited Guest: “CEA versus CAS, Current Status of the CREST trial.” Southern Association for Vascular Surgery (SAVS), Paradise Island, Nassau Bahamas, January 20-23, 2010

Invited Speaker: “Crest may be helpful to advocates of CAS but it is not the final answer: when CEA, when CAS, when best medical treatment: a surgeons perspective” and “Have the results of CEA improved since the landmark trials (NASCET, ACAS, etc) and why?” Veith symposium, New York, New York, November 17-21, 2010.

Invited Speaker: “Carotid Endarterectomy Versus Carotid Angioplasty: results of the Randomized Trials and Analysis” The Houston Aortic Symposium, Houston, Texas, March 24th -26, 2011

Invited Speaker: The Role of CEA and CAS Post Crest and ICSS: What Have We Learned?

UCSF Vascular Symposium 2011, San Francisco, CA, April 7-9, 2011

Invited Speaker: University of Rochester: Visiting Professor – Surgical Ground Rounds presentation entitled “CEA vs. CAS: Current status of the controversy” May 31st – June 3rd, 2011.

Invited Speaker: “Why Have the Safety and Results of Carotid Endarterectomy Continued to Improve” and “Carotid Endarterectomy vs. Carotid Angioplasty: Current Status” at the 32nd Rocky Mountain Vascular Society Meeting in Park City, Utah, July 27th – 30th, 2011

Course Director

& Moderator: 29th Annual UCLA Symposium: A Comprehensive Review and Update of What’s New in Vascular and Endovascular Surgery, Beverly Hills, CA, September 12-15, 2011

Invited Speaker

& Moderator: Carotid Endarterectomy vs Carotid Angioplasty: Current Status of the Controversy and Optimal Contemporary Management of Symptomatic and Asymptomatic Carotid Artery Stenosis at the 12th Annual Asian Society for Vascular Surgery and 6th Annual Asian Venous Forum in Taipei, Taiwan, September 29 – October 2, 2011.

Invited Speaker: “Peripheral Innovations – Have We Really Made a Difference in Outcomes Carotid Stenting“at Cleveland Clinic, October 5-7, 2011

Invited Speaker: Debate: (a) CEA is best for most symptomatic and some asymptomatic carotid stenosis. (b) Why are US health care costs so out of control (c) Radiation associated carotid stenosis is not a hostile neck. VEITH Symposium

Nov 16-20, 2011, New York

Invited Speaker: “Symptomatic carotid stenosis: Still the gold standard? American Heart Association. Nov 12-16, 2011, Orlando, Florida

Invited Speaker: Testify: CMS panel regarding treatment of carotid atherosclerosis. Baltimore, January 28, 2012

Invited Speaker: “CEA- results for trials and technical tips” at the combined STA/AATS/SVS meeting in Ft Lauderdale, January 28, 2012

Invited Speaker: Carotid Stenting: where are we heading? And The New generation of endo- grafts for AAA. Is there any impact on outcomes? At the Annual Surgery Post-Graduate Course held at National Institute of Medical Sciences and Nutrition, Feb 8th – 12, 2012 Mexico City.

Invited Speaker: Randomized Trials of CEA vs. CAS: What do they really show? and Have the results of CEA improved? If so, why? International Society of Surgery Meeting, March 9-11, 2012 Miami, Florida

Course Director

& Moderator: 30th Annual UCLA Symposium: A Comprehensive Review and Update of What’s New in Vascular and Endovascular Surgery, Beverly Hills, CA, September 10-13, 2012

Invited Speaker: Can Patient of Arterial Characteristics Guide the Choice between Carotid Angioplasty and Carotid Endarterectomy? The Carotid Revascularization Endarterectomy versus Stenting. International Stroke Conference 2013, Honolulu, Hawaii, February 6, 2013

Course Director

& Moderator: 31th Annual UCLA Symposium: A Comprehensive Review and Update of What’s New in Vascular and Endovascular Surgery, Beverly Hills, CA,

September 9-12, 2013

Invited Speaker: “Development of Carotid Endarterectomy from inception to present” and “Carotid Endarterectomy versus Carotid Angioplasty: Current Status” LIVE May 22- 24, 2014 – Athens, Greece.

Invited Speaker: “Carotid Surgery – Trials and Tribulations” and CREST 2 Design – Will It Find The Answers? John Homans Distinguished Lecture/SVS, Boston, June 5th 2014

Course Director

& Moderator: 32th Annual UCLA Symposium: A Comprehensive Review and Update of What’s New in Vascular and Endovascular Surgery, Beverly Hills, CA,

September 8-11, 2014

Invited Speaker: Carotid Stent/ angioplasty: Current status and Carotid endarterectomy with patch closure is better than carotid endarterectomy with primary closure. Georgia Vascular Society Meeting, September 12-14, 2014

Invited Speaker: Based on the CREST randomized trial and other data, CEA seems to be the best treatment for symptomatic carotid disease and CMS should NOT expand reimbursement for CAS indications to include average risk symptomatic and asymptomatic patients. Veith Symposium, New York, New York, November 18- 22, 2014

Invited Speaker: Carotid Endarterectomy versus Carotid Stent/Angioplasty: Current Status at the 9th Larry H. Hollis Visiting Professor. Mayo Clinic, August 27-28, 2015

Course Director: 33rd Annual UCLA Symposium: A Comprehensive Review and Update of What’s New in Vascular and Endovascular Surgery, Beverly Hills, CA August 31- September 3, 2015.

Talk: Cerebrovascular Disease II – etiology, diagnosis prognosis and surgery of the carotid artery 33rd Annual UCLA Symposium: A Comprehensive Review and Update of What’s New in Vascular and Endovascular Surgery, Beverly Hills, CA August 31- September 3, 2015.

Invited Speaker: Carotid Endarterectomy vs. Carotid Stent Angioplasty: Current Status and Direct Transcervical Carotid Stent Angioplasty with Flow Reverval using the Silkroad Device. American College of Osteopathic Surgeons 2015 Clinical Assembly in Chicago. October 5, 2015

Invited Speaker: Which plaques are high risk for CAS but not CEA and Surgical management of carotid body tumor. 25th Annual West Virginia Vascular /Endovascular symposium. Greenbrier Resort, Oct. 17-18, 2015.

Invited Speaker: Is Plaque Morphology a Predictor of Neurologic Complications after CAS or CEA at the Controversies and Updates in Vascular Surgery in Paris, France, January 2-23, 2016

Invited Speaker: Poster presentation entitled, Duration of Asymptomatic Status and Outcomes Following Endarterectomy and Stenting in the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST) at the International Stroke Conference on February 18, 2016

Invited Speaker: Carotid Stent/ angioplasty with flow reversal: A New Beginning for CAS and Carotid Endarterectomy vs. Carotid Angioplasty: Current status at Grand Rounds at the Houston Endovascular Club on May 4-5, 2016.

Invited: Visiting Professor for the Department of Surgery of Eastern Virginia Medical School on September 23, 2016.

Invited Speaker: Direct Carotid Stent Angioplasty: A Solution for the Hostile Aortic Arch at the Houston Aortic Symposium on February 23-24, 2017.